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Normal cardiac rhythms are generated by an organized propagation of depolarization and 
repolarization.  The voltage-gated transient potassium current (Ito) is a major determinant of 
cardiac action potential.  The Ito is expressed in a gradient across the left ventricular wall of the 
hearts, which is essential for the proper repolarization sequence in the left ventricle.  Altered 
expression of Ito is seen in hypertrophied and failing hearts and may contribute to the increased 
incidence of cardiac sudden death.  Thus, elucidating mechanisms underlying the expression of 
Ito channels will provide basic knowledge essential for the prevention and treatment of cardiac 
diseases with high public health significance.  
In the mammalian heart, Ito is produced by assembly of pore-forming Kv4 and accessory 
KChIP2 subunits.  Differential expression of Kv4.2 gene underlies transmural gradient of Ito in 
the left ventricle in small rodents, whereas the size of Ito is correlated with different levels of 
KChIP2 in large animals.  Recent studies have shown that atypical homeodomain Iroquois 
proteins are distributed in a gradient in the left ventricle and influence the expression of Kv4.2 
and Ito.  Therefore, this thesis examines the hypothesis that Irx proteins control Kv4.2 gene 
transcription in a cell-type specific manner and analyzes the underlying molecular mechanism.  
Irx3 and Irx5 are differentially expressed in a steep gradient in the left ventricle of rat hearts in 
an inverse pattern to Kv4.2 expression, whereas Irx4 is equally abundant in the ventricle.  Irx5 
activates Kv4.2 promoter in several non-myocyte cell lines, whereas the transcription factor 
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inhibits the promoter activity in neonatal ventricular myocytes.  Moreover, Irx4 prevents Irx5 to 
activate the channel promoter.  Structure-function studies establish that the C-terminus of Irx5 is 
required for its regulation of channel promoter, whereas the N-terminus of Irx4 mediates its 
action.  Addition of histone deacetylase inhibitor relieves the inhibitory effect of Irx4.  Deletion 
and mutation analyses demonstrate the presence of a previously unidentified Irx5-responsive 
element in the Kv4.2 distant promoter region.  Collectively, these results indicate that the 
interplay between Irx4 and Irx5 contributes to the heterogeneous expression of Kv4.2 gene, and 
hence Ito density, in the left ventricle of rat hearts. 
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1.0  INTRODUCTION 
1.1 GENERAL OVERVIEW 
Electrical heterogeneity of cardiac myocytes is essential for normal cardiac rhythms.  
This heterogeneity is produced by different amplitudes of repolarizing potassium current 
expressed in each myocyte.  It has long been noticed that there is a marked regional difference in 
the size of transient outward potassium current (Ito) in the hearts of many species including 
human, rat and mouse.  For example, within the mammalian ventricles, the highest density is 
seen in epicardial myocytes, whereas the lowest is in endocardium.  
Previous investigations have shown that Ito is mediated by heteromeric complexes formed 
by Kv4 α and KChIP2 β subunits.  In small rodents such as mice and rats, differential expression 
of Kv4.2 is largely responsible for this transmural distribution of potassium current, whereas in 
larger mammals it is the distribution of KChIP2 that determines the Ito gradient.  These 
observations indicate a tight control of the transmural gradient of Ito and its fundamental role in 
the maintenance of normal cardiac rhythms.  However, very little is known about transcriptional 
mechanisms underlying the regional differences in these channel subunits in the heart.  
Recent studies have shown that Iroquois (Irx) homeodomain transcription factors are 
expressed differentially across the left ventricular wall in an inverse expression pattern with 
Kv4.2 gene in the hearts of dogs, rats and mice (1, 2).  Therefore, the focus of this study is to 
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identify the roles of Irx proteins in regulating transcription of Kv4.2 gene and the underlying 
molecular mechanisms.  The hypothesis addressed here is that Iroquois family proteins control 
Kv4.2 gene transcription in a cell-type-specific manner.  The overall finding of this study is that 
Irx4 and Irx5 cooperatively regulate transcription of Kv4.2 gene.  Irx5 acts as a primary regulator 
of Kv4.2 gene transcription in myocytes and non-myocytes, while Irx4 is a suppressor of the Irx5 
action.  Structural requirement of Irx proteins for the regulation of channel promoter and 
identification of a cis element in the distal promoter suggest that Irx proteins control channel 
transcription by influencing the activity of other factors.  These results establish the unique roles 
of individual Iroquois family members and the interplay between distinct Iroquois proteins in 
controlling gene transcription.  They also suggest that the levels of distinct Iroquois proteins and 
their interacting partners will determine Kv4.2 gene transcription and electrophysiological 
phenotype of each myocyte.   
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1.2 MOLECULAR PHYSIOLOGY OF THE HEART 
1.2.1      Cardiac Physiology 
The heart is a muscular organ that supplies oxygenated blood and nutrients to the body.  
It is a dual circulatory system by which oxygen-poor blood is sent to the gas-exchange organ, 
whereas oxygen-rich blood is delivered to the entire body.  Mammalian hearts contain two 
pumps each consisting of well-separated two chambers, atrium and ventricle.  The atria act as a 
receiving chamber and booster pump, whereas the ventricles generate a major force to send the 
blood to the target organs.  The right chambers return oxygen-poor blood to the lung, whereas 
the ones on the left send oxygen-filled blood to the entire body.  The left ventricle is larger and 
consists of thicker muscle than the right chamber to generate strong forces necessary for the 
blood to reach terminal tissues. 
The heart contains two functional components: the electrical conduction system and the 
working myocardium.  Cardiac muscles are often characterized by their self-generating rhythmic 
beating.  Indeed, all cardiac myocytes are capable of producing rhythmic action potential and 
beating in the early development.  However, they lose this ability during development.  The pace 
maker cells located at the sinoatrial node, the tip of upper wall of the right ventricle, retain the 
self-generating rhythmic electrical activity in the adulthood.  In contrast, other myocardial cells, 
such as adult atrial and ventricular myocytes, cannot produce action potential in the absence of 
triggers.  The electrical signals originated from the pace maker cells propagate through gap 
junctions between neighboring myocytes and Purkinje fibers, specialized myocytes connecting 
the atrioventricular node, located at the base of atria, to the ventricular walls.  These specialized 
cells and their electrical signal-propagating connections throughout the heart are called the 
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electrical conduction system.  The conduction system plays an essential role in coordinating 
beating myocytes in various heart locations in a synchronized fashion.  
Ventricular myocytes constitute the working component of the heart.  These cells 
typically generate action potentials in a notch-and-dome shape: rapid rise in membrane potential, 
followed by a ditch, sustained period of time at depolarized potential and smooth decline to the 
resting potential.  The sustained period allows an increase in intracellular calcium (Ca2+) 
concentration to induce contraction.  These continuous changes in membrane potential are 
generated by the actions of various voltage-gated ion channels present in these cells.  When 
cardiac myocyte is at rest, the internal and external concentrations of ions maintain in a balance, 
which sets a stable negative membrane potential (resting membrane potential).  A rapid 
depolarization of an action potential occurs due to an activation of voltage-gated sodium (Na+) 
channels and movement of Na+ into the cells.  The influx of Na+ from extracellular fluid raises 
membrane potential.  Once the threshold for the voltage-gated calcium channels is met, Ca2+ 
enters from t-tubules, invagination of plasma membrane.  The increase in intracellular Ca2+ 
facilitates the release of Ca2+ from the sarcoplasmic reticulum, the mechanism called Ca2+-
induced Ca2+ release.  The raised Ca2+ will cause contraction by its troponin binding and sliding 
movement of myofilaments.  The depolarization ends because of the closure of the sodium 
channels at a particular membrane potential.  Meanwhile, voltage-gated potassium (Kv) channels 
open and potassium ions move out of the cells, causing repolarization of the membrane potential 
to return to the resting level.   
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1.2.2     Diversity of Voltage-gated Potassium Channels  
While one type of voltage-gated sodium and calcium currents dominates in ventricular 
myocytes, these cells contain various voltage-gated potassium currents with distinct time- and 
voltage-dependent properties and pharmacological sensitivities.  Voltage-gated potassium 
currents were classically divided into two types: transient outward potassium current (Ito) and 
delayed, outwardly rectifying potassium current (Ik).  The Ito is activated at subthreshold of 
action potential and rapidly inactivates.  It is the major determinant of the early repolarization.  
The delayed rectifier does not show inactivation and is mainly responsible for the late 
repolarization to the resting potential.   
The two types of voltage-gated potassium currents are further classified into several types.  
The delayed rectifier appears to consist of at least three distinct components: Ikr, Iks and Ikur.  The 
first current is very slowly activated without any detectable inactivation, whereas the second 
exhibits complex activation and inactivation kinetics that significantly contributes to the late 
repolarization.  Inherited abnormalities in these currents and drugs affecting these currents are 
known to cause arrhythmias.  The transient outward current is also comprised of two 
components: Ito, fast  (Ito, f) and Ito, slow (Ito, s).  Based on the kinetics of current inactivation and 
recovery from steady-state inactivation, as well as by the sensitivities of channels to the spider 
potassium channel toxins, heteropodatoxins, the two types of transient outward potassium 
currents have been identified in a number of cardiac cell types.  Cardiac Ito, f recovers rapidly 
from steady-state inactivation and is sensitive to heteropodatoxins.  In contrast, the Ito,s  requires 
seconds to restore full activity from inactivation and is insensitive to the toxin.  The Ito, f 
predominates in cardiac Ito in many species, whereas the Ito,s  may increase under pathological 
conditions.   
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1.2.3     Molecular Correlates of Cardiac Voltage-gated Potassium Currents 
Voltage-gated potassium channels are formed by tetramerization of pore-forming 
subunits.  In addition, some channels are associated with ancillary subunits that influence gating 
properties and physiological regulation.  For example, the Ikr,channel appears to be formed by 
the pore-forming KvLQT1 (KCQ1) and auxiliary minK (KCNE1) subunits.  Likewise, ERG 
(KCNH1) constitutes the pore for the Iks channel.  Kv1.5 (KCNA5) and Kv2.1 (KCNB1) are 
considered to be major pore-forming subunits for the Ikur channel. 
The cloning and expression studies have also identified several molecular candidates for 
the cardiac Ito channel.  The first candidates are channels formed by the pore-forming subunit 
Kv1.4 (KCNA4).  Kv1.4 contains a long-stretched amino-terminal peptide that acts as a ball-and-
chain to produce rapid inactivation.  Since Kv1.4 is less abundant in ventricular tissues in many 
species, Kv1.4 may be present as heteromeric channels with other Kv1-family members.  Very 
slow recovery from inactivation of Kv1.4 homomeric and heteromeric channels suggests that 
these channels carry the cardiac Ito,s , a minor component of the Ito.  Other candidates for the Ito 
channels are the ones formed by pore-forming subunits in Kv4 or KCND family.  Kv4.2 
(KCND2), a potassium channel gene, was originally cloned from rat heart (3).  Functional 
studies in Xenopus oocytes expression system have revealed its induction of voltage-dependent 
outward potassium current with rapid inactivation (3, 4).  The use of a dominant-negative Kv4.2 
construct demonstrated that adenovirus-mediated overexpression of a truncated Kv4.2 suppresses 
Ito in adult rat ventricular myocytes (5).  A similar reduction in Ito was later seen in mouse 
ventricular myocytes using a dominant-negative subunit with a missense mutation in the pore 
region (6).  These results established the concept that Kv4.2 gene underlies Ito in mouse and rat 
ventricles.  However, in canine and human hearts, Kv4.2 is less significantly expressed.  Instead, 
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Kv4.3 (KCND3), another Kv4-family member, is abundant in these tissues (7, 8).  Thus, Kv4-
family pore-forming subunits are responsible for the major component of the cardiac Ito.  These 
findings also indicate the species difference in the utilization of Kv4 members: Kv4.2 is the main 
subunit in rodent hearts, whereas Kv4.3 plays the major role in the generation of the Ito channels 
in larger mammals including human.   
Heterologous expression of Kv4.2 or Kv4.3 indicated that these channels exhibit faster 
recovery from inactivation than Kv1.4-containing channels.  Yet, the observed recovery was 
substantially slower than the native Ito,f  in cardiac myocytes.  The auxiliary subunits that interact 
with Kv4 subunits were discovered with the use of cytoplasmic amino-terminal peptide of Kv4.2 
as a “bait” in a yeast two-hybrid screening, and are named Kv channel interacting proteins 
(KChIPs) (9).  Coexpression of Kv4 channels with KChIPs appeared to generate outward 
currents with rapid recovery from inactivation similar to the native Ito,f.  KChIPs are generated 
from four genes (KChIP1-4).  All KChIPs are highly abundant in the brain, whereas only 
KChIP2 is significantly expressed in the heart (9).  Structural analysis has revealed that Kv4 
pore-forming and KChIP accessory subunits assemble in a 4:4 stoichiometry to form a functional 
channel (10, 11).  Therefore, Kv4-KChIP2 complexes underlies Ito,f, the major component of 
transient outward potassium current in ventricular myocytes.  
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1.2.4     The Heterogeneity of Cardiac Action Potential 
The cardiac action potential differs significantly in different portions of the heart.  These 
differences are essential for the proper sequence of cardiac rhythms and beating.  While the 
initiation of action potential is triggered by the electrical signal propagated by the conduction 
system, the duration and shape of action potential are determined by the intrinsic electrical 
properties of individual myocytes.  Earlier studies revealed that the heterogeneity of action 
potential is attributable to the size difference in the transient outward potassium current, Ito.  For 
example, the Ito is significant in epicardium and midmyocardium in the canine ventricular wall 
(12), which gives rise to a notched appearance of the action potential.  In contrast, myocytes in 
endocardium lack Ito, resulting in action potential with long duration without a notch.  Similar 
regional differences in Ito have later been found in feline, rabbit, rat, mouse and human 
ventricular myocytes (13-16).  The transmural gradient in the amplitude of Ito underlies the 
proper repolarization sequence in the left ventricular wall from epicardial to endocardial region 
(17), which has been shown to contribute to the J and T waves of the ECG (18, 19).  
In most species, including human, the differential expression of Ito is the primary 
determinant of action potential heterogeneity and is not exclusive to left ventricular walls.  For 
example, Ito densities are significantly higher in atrial myocytes than ventricular cells in human 
and rat hearts (16, 20).  In contrast, mouse ventricular myocytes contain a larger Ito density than 
atrial cells (21).  In canine and mouse hearts, Ito density is higher in the right ventricle (RV) than 
left ventricle (LV), and lower in the base of the LV than the LV apex.  It is hypothesized that 
these intrinsic electrophysiological heterogeneities are responsible for a normal sequence of 
repolarization in healthy hearts.  Loss of the repolarization heterogeneity can be proarrhythmic 
(22).  The alteration may occur due to drug actions, inherited mutations, or acquired disease.  
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However, the exact functional importance of the heterogeneity of cardiac action potential 
remains largely unknown.  Also the molecular mechanisms that establish and maintain the 
cardiac heterogeneity during normal development, as well as in adult hearts are unclear.   
It appears that Kv4.2 mRNA is differentially expressed in a gradient across the left 
ventricular wall of rodent hearts, with expression eight times higher in epicardium than 
endocardium (7, 23).  In contrast, Kv4.3 message is equally expressed in this tissue.  This 
transmural gradient of Kv4.2 across the left ventricular wall parallels with the gradient of Ito 
density.  However, in larger mammals including human, KChIP2 is differentially distributed 
across the left ventricular wall.  Also KChIP2 protein in canine ventricle parallels with KChIP2 
message, leading to further support to the hypothesis that KChIP2, not Kv4.3, underlies the 
transmural gradient of Ito in canine and human ventricles.  In rat and mouse hearts, KChIP2 
mRNA and protein are equally abundant across the left ventricular wall.  
These findings indicate two important differences regarding Ito channels between rodents 
and large mammals including human.  First, Ito channels reflect the heteromeric assembly of 
Kv4.2/Kv4.3, and KChIP2 in rat and mouse, and Kv4.3 and KChIP2 in large animals.  Second, 
the difference in Kv4.2 expression underlies the regional difference in Ito density in rodents, 
whereas KChIP2 appears to be the primary determinant of the observed regional difference in Ito 
density in large animals. 
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1.3 IROQUOIS HOMEOBOX FAMILY GENES 
The Iroquois homeobox (Irx) family genes encode homeodomain-containing transcription 
factors that play fundamental roles in many developmental processes.  The homeodomain is a 
~60-amino acid peptide consisting of three alpha helices and binds to DNA.  Irx proteins contain 
an atypical homeodomain with the insertion of three amino acids between the first and second 
alpha helices.  Proteins containing this atypical homeodomain are found in plants, fungi and 
animals and constitute the three-amino acid-loop-extension (TALE) superclass.  Little is known 
about the structure or other characteristics of this atypical homeodomain except that it binds to 
DNA in a sequence-selective manner in vitro.  In addition to the atypical homeodomain, Irx 
proteins share a 13-amino acid domain in the carboxyl-terminal region, called the Iro box, 
although no function has been assigned to this domain.  Analysis of the human and mouse 
genomes revealed that there are six Irx-family genes clustered on two loci (24, 25).  In mouse, 
Irx1, Irx2 and Irx4 are on the chromosome 13 to form the IrxA cluster, while Irx3, Irx5 and Irx6 
are on the chromosome 8 as the IrxB cluster (25).  The Drosophila genome contains only three 
Irx genes as a cluster.  Furthermore, the sequence similarity between Irx members indicates that 
the two Irx gene clusters in mammalian genomes may be generated by duplication during 
evolution.   
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1.3.1     Irx4 
Irx4 is the earliest known marker of the ventricular precursors and its cardiac expression 
is restricted to the ventricles during all stages of cardiac development (26, 27).  Mice, frogs, birds 
and fishes have all show ventricle-specific expression of Irx4, suggesting that Irx4 has an 
evolutionarily conserved role in heart development (28).  An ectopic expression experiment in 
chicken embryo has shown that a dominant-negative Irx4 molecule disrupts the chamber-specific 
expression of cardiac myosin heavy chain genes (27).  Moreover, Irx4 deficiency in mouse 
causes an inappropriate expression of atrial genes in the ventricle resulting in adult-onset cardiac 
hypertrophy (26).  However, the mechanism by which Irx4 regulates the expression of these 
cardiac genes is uncertain.  A report suggested that Irx4 represses transcription of the atrium-type 
myosin heavy chain in the ventricle by forming an inhibitory complex with retinoic X receptors, 
instead of interacting with the promoter directly (29).  Therefore, Irx4 at least in part, indirectly 
exerts its effect on gene transcription by interacting with other transcription factors.   
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1.3.2      Irx5 
The Iroquois homeodomain protein 5 (Irx5) was first identified in mouse embryo with a 
similarity to other previously identified Irx members (30).  However, the functional role of Irx5 
is largely unknown.  Very recent studies have shown that Irx5, along with another Iroquois 
homeobox gene Irx3, is differentially expressed across the left ventricular wall in a gradient in 
rat, mouse and canine hearts (1, 2).  These factors are expressed at higher levels in the 
endocardium than epicardium.  Moreover, Irx5-deficient mouse is proarrhythmic due to the loss 
of normal transmural repolarization sequence and Kv4.2 gradient across the left ventricular wall 
(2).  These studies indicate that Irx5 is essential for the generation of transmural gradient of Ito 
across the left ventricular wall likely through regulating Kv4.2 gene transcription.  However, the 
mechanism by which Irx5 controls transcription of Kv4.2 gene remains obscure.  Moreover, the 
roles of other Irx members in the regulation of Kv4.2 gene are unknown. 
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1.4 SUMMARY 
Normal cardiac repolarization is orchestrated by the assortment of various potassium 
currents.  The transient potassium current is the primary determinant of early repolarization and 
influences the time course of repolarization.  It has long been noticed that there is a transmural 
gradient of Ito across the left ventricular wall of the heart in almost all mammalian species.  The 
heterogeneity of Ito is essential for synchronizing cardiac repolarization thereby contributing to 
the generation of normal cardiac rhythms.  An alteration in the Ito gradient due to drug actions, 
inherited mutations (31), or acquired disease (32) can trigger arrhythmia which is the leading 
cause of sudden death.  Despite the pivotal role of the region-selective Ito expression in cardiac 
pathophysiology, very little is known about the mechanism by which this heterogeneity is 
generated during heart development and maintained in adult hearts.  
In the past few years, some progresses have been made in understanding the molecular 
mechanism underlying the generating of transmural gradient of Ito.  It has been found that the two 
Iroquois-family genes (Irx3 and Irx5) are distributed in a gradient across the left ventricular wall 
of adult rat, mouse and canine hearts, with highest expression in endocardium (1).  The 
expression pattern of these transcription factors has made them potential candidates to control 
the regional heterogeneity of Kv4.2 and/or KChIP2 in the ventricle.  Another study has shown 
that deletion of Irx5 gene in mouse abolishes the differential expression of Ito across the left 
ventricular wall, resulting in an increased susceptibility to arrhythmia (2).   
Meanwhile, another Iroquois family member, Irx4, has gained much interest in 
controlling chamber-specific genes expression.  Irx4 deficiency in mouse caused no obvious 
cardiac malformation, but resulting in an inappropriate expression of atrial genes, such as Anf 
and α-skeletal actin in the ventricle, leading to adult-onset cardiomyopathy.  The relative mild 
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phenotype of Irx4-deficient mouse may result from the functional redundancy of other Iroquois 
family members.  A similar functional redundancy has been seen with GATA4, GATA5, 
GATA6 and other transcription factors important for heart development.  Irx4 coordinates both 
up- and down-regulation of various genes that fulfills ventricle-specific functional requirement.  
Therefore, Irx4 may also play important roles in regulating the region-selective Kv channel gene 
expression.  A molecular study revealed that Irx4 forms an inhibitory heteromeric complex with 
retinoid X receptor α (RXR α) and vitamin D receptor (VDR) to repress the promoter activity of 
the smyHC3, a gene that is specifically expressed in the atria (29).  It is unclear whether this 
ventricle-restricted repression mechanism by Irx4 found for the myosin heavy chain gene applies 
to other genes.  Taken together, these recent studies all implied important roles of Iroquois 
transcription factors in controlling the chamber- and region-selective transcription of genes.    
Therefore, the current study focuses on the potential roles of Iroquois family members in 
the regulation of Kv4.2 gene transcription.  This study is also aimed at elucidating the cellular 
context in which these factors influence channel gene transcription.    
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               2.0    THE EFFECTS OF IROQUOIS PROTEINS ON TRANSCRIPTION OF THE RAT 
KV4.2 GENE 
2.1 ABSTRACT 
It is well established that there is a gradient of Kv4.2 gene expression across the left 
ventricular wall in the hearts of small rodents (23).  This differential expression evidently 
parallels with the transmural gradient of Ito.  However, a fundamental question about how this 
potassium channel gene is transcriptionally regulated remains to be answered.  Recent studies 
showed a regional difference in Iroquois homeodomain protein 5 (Irx5) in the left ventricle of 
mouse and rat hearts (1, 2).  Irx5 belongs to a family of transcription factors that are essential for 
cellular speciation and morphogenesis during development.  Therefore, the mRNA levels for all 
Iroquois family members and potassium channel pore-forming subunits in various regions of rat 
heart were first examined in this study.  Irx3 and Irx5 were expressed in a steep gradient across 
the left ventricular wall in an inverse pattern to the expression of Kv4.2 gene.  In contrast, Irx4 
was equally abundant throughout the ventricular tissue.  Other Irx members were either 
undetectable or very low without any region selectivity.  Luciferase reporter gene assays were 
then used to test the effects of differentially-expressed Irx3 and Irx5, as well as abundant Irx4, on 
Kv4.2 promoter.  Irx5 influenced the promoter activity of rat Kv4.2 gene in a cell-type specific 
manner: it decreased the promoter activity in neonatal ventricular myocytes and increased the 
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activity in 10T1/2 cells (a murine embryonic fibroblast cell line).  Irx4 appeared to suppress the 
Irx5-induced enhancement of promoter activity in fibroblast cells.  The dose relationship 
between Irx4 and Irx5 indicated that the ratio of Irx5/Irx4 might determine the level of Kv4.2 
gene transcription.  Furthermore, Irx4 siRNA was employed to reduce the endogenous 
expression of Irx4 in neonatal myocytes.  The siRNA-mediated suppression abolished the 
inhibitory activity of Irx5 and further increased Kv4.2 promoter activity in response to Irx5.  
Thus, Irx5 acts as a primary regulator of Kv4.2 gene transcription with opposite effects in 
myocytes and non-myocytes, whereas Irx4 suppresses the stimulatory activity of Irx5.  Given the 
abundant expression in the rat ventricle, Irx4 might constitutively prevent the stimulatory effect 
of Irx5 and, at least partially, be responsible for, the inverse relationship between Irx5 and Kv4.2 
levels across the left ventricular wall. 
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2.2 INTRODUCTION 
In the mammalian heart, there is a marked regional difference in the shape and duration 
of action potential.  It is hypothesized that this spatial heterogeneity of action potential is 
responsible for the normal spread of excitation and the proper dispersion of repolarization in the 
heart.  One such example is the pronounced transmural gradient of repolarization current (Ito) 
across the left ventricular wall.  Ito is voltage-dependent transient outward potassium current that 
contributes to the early stage of repolarization and influences the time course of action potential.  
The cardiac Ito channels are produced by assembly of pore-forming Kv4.2 and/or Kv4.3 and 
accessory KChIP2 subunits.  In small rodents, differential expression of Kv4.2 gene is the 
molecular basis of the Ito gradient across the left ventricle wall.  Despite the fact that the 
transmural gradient of Kv4.2 has been documented for a long time (23), the mechanism 
underlying this region-selective expression remains largely unknown.  In addition, the 
downregulation of Kv4.2 gene expression has been seen in hypertrophied and failing hearts in 
various animal studies (33-35).  Yet, little studies have examined the transcriptional regulatory 
mechanism controlling Kv4.2 gene.  Our laboratory has isolated rat Kv4.2 promoter and 
characterized the basal promoter lacking TATA box (36).  Identification of this promoter 
promoted us to elucidate the molecular mechanism underlying the region-selective Kv4.2 gene 
transcription.   
The Iroquois (Irx) atypical homeobox genes encode a family of transcription factors 
implicated in key developmental processes in both vertebrates and invertebrates.  They are 
characterized by the presence of a highly conserved 63-amino acid homeodomain with a 3-amino 
acid extension, which places them into the three-amino acid-loop-extension (TALE) superclass 
(37).  Outside the atypical homeodomain, Irx proteins share little sequence similarity, but all 
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contain a highly conserved 13-amino acid motif, called the Iro box.  Yet, functional roles of 
these domains and other diverse regions largely remain unclear. 
The Iroquois homeobox genes, ara and caup, were first identified in Drosophila and 
control proneural genes expression (38, 39).  The vertebrate Iroquois homeobox genes show 
localized expression patterns and encode transcription factors that are essential for organogenesis 
and regionalization during embryonic development of various organs, such as kidney, brain, lung 
and heart (40-43).  
Earlier studies have shown that the cardiac expression of Irx4 is restricted to the ventricle 
to control the expression of chamber-specific genes (26, 27).  For instance, Irx4 suppresses the 
atrial myosin heavy chain-1 gene expression (MyHC-1) and stimulates the ventricular MyHC-1 
expression in the ventricle of embryonic chicken (27).  Similarly, deletion of the Irx4 gene in 
mouse caused aberrant ventricular gene expression including decreased expression of eHand and 
inappropriate postnatal ventricular expression of ANF, α-skeletal actin, and βMHC, therefore 
resulting in adult-onset cardiac hypertrophy (26).  The role of Irx4 in directing chamber-specific 
gene expression has further been confirmed by experiments of mating Irx4-deficient mice to 
transgenic mice expressing a reporter gene under the control of the atrium-restricted slow myosin 
heavy chain 3 (sMyHC3) promoter.  The lack of Irx4 caused the appearance of the atrial specific 
promoter-driven reporter in the left ventricle (26).  A detailed in vitro functional study showed 
that Irx4 indirectly influences the sMyHC3 gene expression by forming heteromeric complexes 
with VDR and RXRα that bind to the vitamin D response element (VDRE) in the slow MyHC3 
gene promoter (29).   
Other Iroquois members that may play important roles in controlling region-selective 
genes expression in the heart include Irx5.  Irx5 cDNA was initially isolated from a cardiac 
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library using the conserved homeobox region of the chicken Irx4 as a probe (44).  Recent studies 
suggested the importance of Irx5 in controlling the region-selective expression of Kv4.2 gene in 
the heart.  A microarray analysis and RNase protection assays have shown a transmural gradient 
of Irx3 and Irx5 expression across the left ventricular wall of rat and canine hearts in an inverse 
pattern to that of the Kv4.2 gene (1).  Costantini et al. (2005) made a more intriguing observation 
that Irx5-deficient mice lack the gradient of cardiac repolarization due to increased expression of 
Kv4.2 gene in the endocardium, resulting in an increased susceptibility to arrhythmia.  They also 
showed that Irx5 represses Kv4.2 promoter activity by recruitment of the muscle transcription 
repressor mBOP.  Taken together, these studies suggested pivotal roles of Iroquois proteins in 
determining the region-selective gene expression patterns in the heart.  However, the molecular 
framework by various Iroquois members in controlling transmural gradient of Kv4.2 remains 
unclear.  Therefore, we first performed a full examination of the expression of Iroquois family 
members and Kv channel pore-forming subunits in various regions of rat heart.  In addition, the 
effects of various Iroquois members on the promoter activity of Kv4.2 gene were examined.  The 
data presented in this chapter clearly indicate that Irx5 regulates Kv4.2 gene transcription in a 
cell-type specific manner.  Also the relative ratio of Irx5/Irx4 determines the promoter activity of 
Kv4.2 gene.  These findings imply that the cooperation of Iroquois family members is essential 
for establishing the transmural gradient of Kv4.2 gene in rodent hearts. 
 19 
2.3 METHODS AND MATERIALS 
2.3.1     Cell Culture and Reagents 
2.3.1.1      10T1/2 Cells 
Murine C3H 10T1/2 fibroblast cell line was originally obtained from American Type 
Culture Collection (ATCC, Manassas, VA) and maintained in the laboratory.  It is derived from 
early mouse embryo and exhibits less differentiated fibroblast properties.  These cells were 
grown at 37ºC under 5% CO2 atmosphere in Basal Medium Eagle (BME) (Invitrogen, Carlsbad, 
CA) supplemented with 10% fetal bovine serum (FBS) (Hyclone, Logan, UT) and 1% L-
glutamine (Invitrogen, Carlsbad, CA).  The cells were passed just before confluence.  
2.3.1.2     Neonatal Ventricular Myocyte 
Primary cultures of neonatal cardiac myocytes were prepared from the ventricles of 1-
day-old Sprague-Dawley rat pups as described previously (45).  Neonatal ventricular myocytes 
were plated on 60-mm plastic dishes with Minimal Essential Medium (Invitrogen, Carlsbad, CA) 
supplemented with 5% calf serum and antibiotics overnight in a humidified incubator with 1% 
CO2 at 37ºC.  The medium was then changed to the one without serum for further culture.  
Myocytes were maintained in serum-free medium for the entire experimental period.   
2.3.1.3   HEK293 Cells 
            HEK293 human embryonic kidney epithelial cells were originally obtained from ATCC 
American Type Culture Collection (ATCC, Manassas, VA) and maintained in our laboratory.  
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Cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen, Carlsbad, CA) 
supplemented with 10% FBS at 37ºC under 5% CO2 atmosphere.  
2.3.1.4       Reagents   
Anti-Myc and anti-Flag monoclonal antibodies were purchased from Sigma (St. Louis, 
MO).  Anti-GFP was from MBL (Nagoya, Japan).  Secondary antibodies conjugated with 
horseradish peroxidase were from Jackson Laboratories (West Grove, PA).  Chemiluminescent 
reagents were from Pierce (Thermo Fisher Scientific Inc., Rockford, IL).  Synthetic 
oligonucleotides were from Integrated DNA Technologies (Coralville, IA) unless otherwise 
specified.   
2.3.2     RT-PCR Analysis 
2.3.2.1      Animal Care and Tissue Isolation 
The animal investigation conforms to the Guide for the Care and Use of Laboratory 
Animals published by the U.S. National Institutes of Health (NIH Publication No. 85-23, revised 
1996) and was performed under the animal protocol approved by the University of Pittsburgh 
Animal Committee.  Hearts were obtained from 12-weeks old male Sprague-Dawley rats 
obtained from Taconic (Hudson, NY).  Various heart regions were dissected using fine scissors 
and forceps, rapidly frozen on dry ice, and stored in liquid nitrogen (-70ºC).   
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2.3.2.2      Total RNA Isolation from Tissue Samples 
Total RNA was isolated by one step extraction with acid phenol-chloroform guanidium 
thiocyanate (46).  Briefly, frozen tissues were crashed into powder-like pieces in liquid nitrogen.  
The crashed tissues were homogenized in denaturing solution (solution D: 4M guanidinium 
thiocyanate, 25mM sodium citrate, pH 7; 0.5% sarcosyl, 0.1M 2-mercaptoethanol) using a 
polytron homogenizer (PowerGene 700, Fisher) at speed 20.  The homogenate was mixed 
vigorously with 0.1 volume of sodium acetate (pH 5), one volume of water-saturated phenol and 
0.2 volume of chloroform-isoamylalcohol (49:1).  The mixture was centrifuged at ~10,000 g for 
30 minutes at 4ºC.  The obtained aqueous layer was mixed with one volume of isopropanol, and 
RNA was precipitated by centrifugation.  The isolated crude RNA was further purified using a 
column-based method (RNeasy Mini Kit, Qiagen, Valencia, CA) according to the manufacturer’s 
instructions.  RNA concentrations were determined spectrophotometrically using the absorbance 
at 260 nm = 40 μg. RNA samples were stored at -80ºC until used.  
2.3.2.3   Reverse Transcription and Polymerase Chain Reaction (RT-PCR) 
First strand cDNA was synthesized with 2.5 μg of total RNA in a 20-μl reaction, using 
oligo(dT)20 primer and ThermoScript RT-PCR System (Invitrogen, Carlsbad, CA) at 50ºC for 1 
hour.  For a standard PCR reaction, 0.5 μl of the synthesized cDNA was used in a 25-μl PCR 
reaction containing 2.0 mM MgCl2, 0.2 mM dNTPs, 1.25 U Taq DNA polymerase (Genechoice, 
Frederick, MD), and 0.5 μM forward and reverse primers (Table 1).  The standard amplification 
protocol was 1 minute denaturation at 94°C and 14-35 cycles consisting of 94°C for 10 seconds, 
58-62°C for 10 seconds, and 72°C for 1 minute, followed by a final extension at 72°C for 4 
minutes.  Different cycle numbers and amounts of cDNAs were used to test the linearity of PCR 
reactions.  The level of mRNA was estimated from the data that were in the linear range with 
 22 
respect to the amount of cDNA used.  cDNA produced without reverse transcriptase was used as 
negative control.  These negative controls yielded no detectable signals at the expected size in 
the standard PCR at 35 cycles.  PCR products were separated on a 1.8% agarose gel and 
visualized by ethidium bromide staining.  Stained gel images were captured, and band intensities 
were analyzed using a charge-coupled device camera-based system (BioChem II; UVP, Upland, 
CA).  
Table 1.  Primers Used for RT-PCR Analysis 
Name Sequence Position Size GeneBank# 
Irx1 AACGAAGACGAGGAGGACAA 724-743 386 XM_343741.1 
TTGCCTATGTGGCAGGTGTA 1109-1090
Irx2 TACGCACCTGTCACTCAAGG 1333-1352 362 XM_225077.2 
TCATCGTCCTCCTCATCCTC 1694-1675
Irx3 AGCCCAAGATCTGGTCACTG 1019-1119 386 XM_226322.2 
TTCTCCACTTCCAAGGCACT 1484-1465
Irx4 TGCTGATGGAGCTGTTATGG 939-958 333 XM_225068.2 
TGGTGCCTATCCAGAGTTCC 1271-1252
Irx5 CCACAGAAGCCCGAGGACA 607-625 352 DQ109812 
GTGGTGAGTGGATGACCGAG 958-939 
Irx6 GCTGTCAAAGCTGTGCATGT 1144-1163 262 XM_226359.2 
CTTGGAAAAGCATCCGTAGC 1405-1386
Hand1 ACGAACCCTTCCTCTTTGGT 80-98 379 NM_021592.1 
AGCACGTCCATCAAGTAGGC 458-439 
Hand2 CGAGGAGAACCCCTATTTCC 139-159 351 NM_022696.1 
GATCCATGAGGTAGGCGATG 489-470 
GADPH GCCATCACTGCCACTCAG 1381-1397 148 NM_017008 
GTGAGCTTCCCGTTCAGC 1528-1512
mBOP GGCCAAACTGCACTGTCATA 968-987 217 (Long) XM_216172 
TCTGGCAGTGTTCACAGGAG 1183-1164 177 (Short) 
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2.3.2.4   Real-time Polymerase Chain Reaction  
 Taqman-based real-time PCR for Kv channel and Irx mRNA was performed with 
primers probes listed in Table 2.  The PCR reaction was done with 200 nM primers and 100 nM 
5’ 6-FAM/ 3’TAMRA-labeled probe (Integrated DNA Technology, Coralville, IA) on an ABI 
Prizm-7000 machine.  A commercially available rat β-glucuronidase kit was used as a 
normalization control (Applied Biosciences, Foster City, CA).  The same brain RNA was used as 
an internal control for all experiments, and Kv channel mRNA levels were determined with a 
threshold cycle (CT) with the comparative CT method using the value obtained with the brain 
RNA.  Irx4 and Irx5 mRNA levels were estimated by real-time analysis with SYBR green dye 
using a commercially available master mix (Applied Biosystems, Foster City, CA) on an Opticon 
DNA engine equipped with a continuous fluorescence detection system (MJ Research, Waltham, 
MA).  Primers used for semi-quantitative assays in Table 1 were used for this analysis.  A series 
of dilution of a targeted gene cDNA were used as a positive control to estimate the copy number 
of the transcript using CT.   
2.3.3      Constructions 
2.3.3.1      Irx3, Irx4 and Irx5 
Full-length rat Irx3, Irx4 and Irx5 cDNAs were obtained by multiple RT-PCR with 
primers (Table 1) that were designed based on the sequences of rat and mouse cDNAs using 
high-fidelity DNA polymerase (Phusion, Finnzymes, Espoo, Finland).  Obtained cDNA 
sequences were verified by direct sequencing with the established cDNA and genomic 
sequences.  Identified misincorporations were fixed using two primer-based mutagenesis 
(Quickchange XL II, Stratagene, La Jolla, CA).  Irx cDNAs were then cloned into 
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cytomegalovirus-based mammalian expression vector (pcDNA3) (Invitrogen, Carlsbad, CA).  
These cDNAs were also cloned into the two vectors that are designed to produce epitope-tagged 
target proteins: p3x FLAG-CMV-10 expression vector for three Flag tags at the N-terminus of a 
target protein (Sigma-Aldrich, St. Louis, MO) and pCS2+MT for six Myc tags at the N-terminus 
of a target proteins (a gift from Dr. Angeles B. Ribera, University of Colorado Health Center).  
2.3.3.2   mBOP 
 Full-length cDNAs for rat mBOP splicing variants and a partial cDNA for mouse 
skeletal nascent polypeptide-associated complex (skNAC) were obtained by RT-PCR.  The latter 
cDNA corresponded to the amino acid 1141-2187.  mBOP cDNAs were cloned into pcDNA3 or 
N-terminally-tagged in pCS+MT, whereas skNAC peptide cDNA was in Flag10.  
2.3.3.3   Small Interfering RNAs 
Two siRNAs targeted to rat Irx4 were synthesized (Table 7) in which two thymidines 
were added at the 3’end of the target sequence.  As a control, a commercially available negative 
control (Silencer® Negative Control #1 siRNA, Ambion, Austin, TX) was used. 
 
Table 2.  Irx4 RNA Interference Used For This Study 
siRNA Sense strand Anti-sense strand 
Irx4 siRNA-1 5’-CUCCCUGAGCACGUGCUG 
Ctt-3’ 
5’GCAGCACGUGCUCAGGG 
AGtt-3’ 
Irx4 siRNA-2 5’-CUCAAUUCUGCCGCCGCG 
Ctt-3’ 
5’GCGCGGCGGCAGAAUUG
AGtt-3’ 
 
 25 
2.3.4       Reporter Gene Assays 
2.3.4.1      Transfection of Plasmid DNAs into 10T1/2 Cells 
A luciferase reporter gene (pGL3-basic) containing the region between -1094 and +592 
of the rat Kv4.2 gene was generated as previously described (36).  10T1/2 cells were seeded on 
6-well plates with 50% confluence.  Kv4.2 promoter (-1094~ +592) -reporter gene, pRL-tk 
containing the HSV thymidine kinase promoter linked to Renilla luciferase (Promega, Madison, 
WI), and pcDNA3 for rIrx3, rIrx4 or rIrx5, were transfected into 10T1/2 cells using 
Lipofectamine 2000 (Invitrogen, Carlsbad, CA) at 1 μg DNA: 2 μl transfection reagent ratio for 
3 hours in the absence of serum.  To test the promoter activity by mBOP, 10T1/2 cells were 
transfected with various amounts of expression vector for mBOP (0.1, 0.2, 0.5 μg) with the 
presence of expression constructs for Irx.  Total amount of expression vector was kept constant 
by supplementing empty vector.  The transfected cells were cultured in the complete medium for 
one more day before harvesting for luciferase assay.  
To test the promoter activity by mBOP, 10T1/2 cells were transfected with various 
amounts of expression vector for mBOP (0.1, 0.2, 0.5 μg), Kv4.2 promoter (-1094~ +592)-pGL3 
basic, and/or 0.2 μg Irx5.  Total amount of expression vector was kept constant by 
supplementing empty vector.  
2.3.4.2   Transfection of Plasmid DNAs into Neonatal Myocytes 
            Two days after preparation, neonatal myocytes on 60-mm plastic dishes were transfected 
with Kv4.2 promoter (-1094~ +592)-pGL3 basic, expression constructs for rIrx3, rIrx4 or rIrx5 
and pRL-tk at 1 μg DNA: 2 μl transfection reagent ratio.  Total amount of expression vector was 
kept constant by supplementing empty vector.  The transfected cells were maintained in 5% calf 
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serum-containing medium overnight, and then cultured in the serum-free medium for an 
additional day before luciferase assay.  
2.3.4.3    Evaluation of Effectiveness of siRNA and Transfection of siRNA into Neonatal 
Myocytes 
To evaluate the efficacy of siRNAs to reduce Irx4 protein, siRNA (10 or 50 nM), Flag-
Irx4 cDNA (2 μg) and EGFP-C1 (0.5 μg, BD Bioscience, San Jose, CA) were transfected into 
HEK293 cells on a 60-mm dish using Lipofectamine 2000 at 1 μg DNA: 2 μl transfection 
reagent ratio.  Two day after transfection, anti-Flag and anti-GFP immunoreactivities were 
measured by immunoblot analysis.      
Neonatal ventricular myocytes on 60-mm plastic dishes were transfected with 0.4 μg 
Kv4.2 promoter luciferase construct, 0.2 μg and 50 nM siRNA using Lipofectamine 2000 at 1 μg 
DNA: 2 μl transfection reagent ratio for 3 hours.  Two days after transfection, cells were 
harvested for dual luciferase assays.  
2.3.4.4    Luciferase Assay  
Transfected cells on plastic dishes were washed with ice-cold phosphate-buffered saline 
(PBS) and harvested by scraping off from plastic surface using a plastic lifter in a small volume 
of PBS.  The cell pellets were collected by centrifugation at 2000 rpm for 1 minute, followed by 
washing with ice-cold PBS.  The cells were lysed with 1x Passive Lysis buffer provided with the 
dual-luciferase reporter assay system (Promega, Madison, WI).  Firefly and Renilla luciferases 
were continuously detected according to manufacture’s instruction using Turner Luminometer 
20-20 (Sunny Vale, CA).   
 27 
Irx5, as well as Irx4, influenced activity of the thymidine kinase promoter in neonatal 
myocytes and 10T1/2 cells.  However, all firefly readouts used in this study were normalized to 
Renilla luciferase levels since this normalization provided more consistent results without 
altering the direction or statistical significance of changes. 
2.3.5     mBOP Immunoprecipitation 
2.3.5.1     Transfection  
10T1/2 cells in a 100-mm plastic dish were transfected with 5 μg of Myc-mBOP (long 
splicing variant), and 5 μg of Flag-Irx, Flag-skNAC peptide or empty vector using the method 
described above.   
2.3.5.2    Immunoprecipitation  
One day after transfection, cells were collected with ice-cold PBS.  Cell lysate was 
prepared by suspending the collected cell pellet in 400 μl of lysis buffer containing 20 mM Tris-
HCl (pH 7.5), 1% Triton X-100, 0.2 M NaCl and 1 mM EDTA supplemented with protease 
inhibitor cocktails (Complete, Roche, Indianapolis, IN).  After centrifugation at 10,000 xg for 10 
minutes, the obtained supernatant was referred as to cell extract.  Cell extract was incubated with 
protein-G agarose (Sigma-Aldrich, St. Louis, MO), monoclonal anti-Flag M2 or anti-Myc 
antibody (2 μg) for 2 hours at 4 ºC on a rotating plate for immunocomplex formation.  The bound 
materials were collected by centrifugation and washed four times with the same ice-cold lysis 
solution.  The bound proteins were then eluted by mixing with 2 x SDS sample buffer at room 
temperature and analyzed by immunoblot analysis.  
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2.3.5.3   Immunoblot Analysis 
Samples were separated on a 10% SDS-polyacrylamide gel and transferred to 
nitrocellulose membrane.  The membrane was blocked with 5% nonfat dry milk in 1x PBST 
(PBS supplemented with 0.1% Tween 20) overnight at 4 ºC.  The coated membrane was probed 
with monoclonal anti-Flag or polyclonal anti-Myc antibodies at 4 ºC for 2 hours.  The membrane 
was washed with 1x PBST for 3 times, followed by incubation with a horseradish peroxidase-
conjugated secondary antibody at room temperature for 1 hour.  The membrane was washed for 
4 times with 1x PBST.  The immunoreactive proteins were detected with chemiluminescent 
reagents (Supersignal WestPico, Pierece, Thermo Fisher Scientific Inc. Rockford, IL).  
Chemiluminescence images were captured and analyzed using charged-coupled device camera-
based system (BioChem II; UVP, Upland, CA).              
2.3.6      Statistical Analysis 
Each luciferase value was obtained as the average of duplicate assays.  Luciferase values 
obtained from at least three independent experiments were used for statistical analysis.  
Statistical comparison was performed by one-way ANOVA, followed by Bonferroni’s posthoc 
test, using Prism 5.0 (GraphPad Software, San Diego, CA).  The threshold for statistical 
significance was set at the p value less than 0.05. 
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2.4 RESULTS 
2.4.1      Irx Members Are Differentially Expressed in Various Heart Regions 
Previous studies revealed that Irx3 and Irx5 mRNAs are expressed in a gradient across 
the left ventricular wall of rodent and canine hearts (1).  Since Iroquois transcription factors are 
known to control heart morphogenesis and chamber-specific gene expression (44, 47, 48), the 
expression of all Irx members and some related factors in various regions of rat hearts were 
examined using semi-quantitative assays (Fig. 1A and B).  Irx3 and Irx5 mRNA levels appeared 
to be ~5-times and more than ~15-times higher, respectively, in the endocardial layer than the 
epicardial region.  Using the same samples, it was found that Kv4.2 mRNA level was ~5-times 
more abundant in the epicardial layer than the endocardial portion.  Real-time analyses revealed 
similar differential expression of Irx5 and Kv4.2 mRNAs across the left ventricular wall (Fig. 2A 
and B): Kv4.2 mRNA level was 5.1± 0.7-fold higher in the epicardial region than the 
endocardial portion (n=4).  Irx5 mRNA level was 18.6± 7.9-fold more abundant in the 
endocardial layer than the epicardial region (n=3).  In contrast, Irx4 was equally abundant 
throughout the rat ventricular tissue (Fig. 1A and B for Irx4).  Likewise, Kv4.3 mRNA was 
constantly expressed across the left ventricular wall.  Thus, the expression of Irx3 and Irx5 
mRNAs is inversely related to that of Kv4.2 message across the left ventricular wall of adult rat 
heart.   
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 Figure 1.  Irx3 and Irx5 mRNAs are differentially expressed across the left ventricular wall of rat 
heart by semi-quantitative PCR. 
(A) RT-PCR analysis was performed with total RNAs isolated from indicated regions of adult rat heart.  Left 
ventricular free wall (L.V.) was dissected into three layers with equal thickness: endocardial (Endo), midlayer (Mid), 
and epicardial (Epi) layers.  (B) Levels of Kv4.2, Kv4.3, Irx4 and Irx5 mRNAs were determined with 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA as a control.  Points and error bars represent the mean 
and S.E.M., respectively (n=4 for each point). 
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 Figure 2.  Irx5 mRNAs are differentially expressed across the left ventricular wall of rat heart in an 
inverse pattern to that of the Kv4.2 gene by real time PCR. 
The levels of Kv channel and Irx factor mRNAs were measured using real-time analyses, as described in Materials 
and Methods.  (A) Kv4.2 and Kv4.3 mRNA levels were plotted on the same scale, whereas (B) Irx4 and Irx5 
messages were on different scales.  Points and error bars represent the mean + S.E.M. (n=4 for Kv4.2 and Kv4.3, 
and n=3 for Irx4 and Irx5). 
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2.4.2     Irx5 Influences Kv4.2 Promoter in a Cell Type-Specific Manner 
Irx5 has been reported to inhibit and activate rat Kv4.2 gene promoter in neonatal mouse 
cardiomyocytes and 10T1/2 fibroblastic cells, respectively (2).  Luciferase reporter gene assays 
were used to test if differentially expressed Irx3 and abundant Irx4 might similarly influence rat 
Kv4.2 gene promoter.  Because the region upstream of -1094 strongly inhibits channel promoter 
activity, the luciferase gene fused with the region between -1094 and +592 of the rat Kv4.2 gene 
was used (36).  As expected, Irx5 decreased and increased channel promoter activity in neonatal 
ventricular myocytes and 10T1/2 cells, respectively (Fig. 3).  In cardiac myocytes, the reduction 
in promoter activity was evident with lower doses of Irx5 and no apparent effect at higher doses 
(Fig. 3A).  The promoter activation by Irx5 showed no reversal with increasing amounts of the 
transcription factor in fibroblastic cells (Fig. 3B).  Unlike Irx5, Irx3 or Irx4 caused no significant 
change in channel promoter activity in any cell types.  In parallel transfection, the expression of 
Flag-tagged Irx members in 10T1/2 cells showed comparable levels (Fig. 4C), indicating that the 
observed specificity is not due to the difference in expression of transfected genes.  Therefore, 
Irx5 specifically inhibits Kv4.2 gene transcription in neonatal ventricular myocytes, whereas the 
transcription factor activates the channel promoter in fibroblasts. 
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 Figure 3.  Irx5 decreases and increases Kv4.2 promoter activity in neonatal ventricular myocytes and 
10T1/2 cells, respectively. 
Neonatal ventricular myocytes (A) and 10T1/2 cells (B) were transfected with indicated amounts of expression 
vector for Irx3, Irx4 or Irx5, Kv4.2 promoter-luciferase construct and pRL-tk. Total amount of expression vector 
was kept constant by supplementing empty vector.  *p<0.05 and ** p<0.01 compared to control (no Irx cDNA) (n>5 
for each condition). 
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2.4.3     mBOP Does Not Affect the Induction of Promoter Activity by Irx5 
A previous study has shown that the muscle-specific transcription factor, mBOP, 
physically interacts with Irx5 and suppresses the Irx5-induced activation of the channel promoter 
in 10T1/2 cells (2).  RT-PCR detected long and short splicing isoforms of mBOP in the rat heart 
(Fig. 4A).  Total mBOP mRNA levels, as well as the ratio of the two variants, were nearly 
identical throughout the heart.  Reporter gene assays were then used to examine if long- or short-
splicing variants of mBOP might affect Kv4.2 promoter activity or its regulation by Irx5 in 
10T1/2 cells (Fig. 4B).  The long or short variants of mBOP by itself produced no significant 
effects on channel promoter.  In the presence of Irx5, mBOP caused a slightly higher promoter 
activity compared to Irx5 alone.  Therefore, mBOP appeared to lack any regulatory activity on 
Kv4.2 promoter, unlike the previous observation.   
Immunoprecipitation was used to test if mBOP might physically interact with Irx 
proteins.  The skeletal isoform of nascent polypeptide-associated complex alpha subunit 
(skNAC) is known to associate specifically with mBOP (49).  Therefore, a portion of skNAC 
containing the identified association site was used as a positive control.  As expected, skNAC 
peptide appeared to interact with mBOP.  In contrast, Irx4 or Irx5 were unable to exhibit any 
significant association with mBOP (Fig. 4C with the long splicing variant).  Therefore, an 
alternative mechanism was sought for the cell type-specific regulation of the channel promoter 
by Irx5.  
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 Figure 4.  mBOP doesn't affect the induction of promoter activity by Irx5. 
 (A) Semi-quantitative PCR analysis was performed with total RNAs isolated from indicated regions of adult rat 
heart.  Strong upper (216-bp) and weak lower (177-bp) bands correspond to the long and short splicing variants of 
mBOP.  (B) 10T1/2 cells were transfected with indicated amounts of expression vector for mBOP, 0.2 μg Irx5 and 
Kv4.2 promoter-luciferase construct.  Total amount of expression vector was kept constant by supplementing empty 
vector.  (C) 10T1/2 cells were transfected with Myc-mBOP (long splicing variant) and indicated Flag-Irx, Flag-
skNAC peptide or empty vector.  Extract was prepared with 1% Triton X-100 and immunoprecipitation was 
performed with anti-Flag antibody.  Extract and immunoprecipitate (anti-Flag IP) were subjected to immunoblot 
analysis.  Arrow heads indicate the position of indicated proteins.  IgGH and IgGL indicate IgG heavy and light 
chains, respectively. 
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2.4.4      Irx4 Specifically Represses the Induction of Promoter Activity by Irx5 
Because Irx members may form homomeric and heteromeric dimmers (50), co-
expression of different Irx members might affect the Irx5-induced promoter activity of Kv4.2 
gene.  Specifically, RT-PCR analysis in this study detected abundant expression of Irx4 in adult 
heart (Fig. 1).  Thus, it was tested if co-expression of Irx4 might alter the outcome of the Irx5-
induced regulation of Kv4.2 promoter.  Co-expression of Irx4 appeared to suppress the Irx5-
induced increase in promoter activity in 10T1/2 cells (Fig. 5A).  This suppression occurred in an 
Irx4 dose-dependent fashion at the constant amount of Irx5, and higher doses of Irx4 were 
required when Irx5 was present at a higher level.  In contrast, Irx3 produced no significant effect 
on the Irx5-induced enhancement (Fig. 5B).  Furthermore, when a constant level of Irx4 was 
present, more Irx5 was required to induce activation of the channel promoter (Fig. 5C).  Again, 
with greater levels of Irx4, more Irx5 were necessary to cause promoter activation.  Thus, Irx4 
specifically suppresses the Irx5-induced activation of Kv4.2 promoter in fibroblastic cells.  The 
observed dose relationship suggests that the ratio of Irx5/Irx4 determines the degree of promoter 
activation. 
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 Figure 5.  Irx4 suppresses the Irx5-induced increase in Kv4.2 promoter activity in 10T1/2 cells. 
 (A and B)  Various amounts of Irx4 or Irx3 cDNA were transfected with a constant amount of Irx5 cDNA or empty 
vector (None).  (C) Various amounts of Irx5 cDNA were used with a constant Irx4 cDNA or empty vector (None).  
Note that the ratio of Irx5/Irx4 is correlated with the degree of channel promoter activation. 
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2.4.5      Irx4 siRNA Suppresses the Inhibition of Irx5 on Kv4.2 Promoter Activity in 
Myocytes 
Abundantly expressed Irx4 might constantly inhibit the activation action of Irx5 in 
cardiac myocytes.  Thus, reducing Irx4 in neonatal myocytes might influence the outcome of 
Irx5-induced regulation in neonatal myocytes (Fig. 6).  Two siRNAs for Irx4 with different 
efficacies were used to decrease Irx4 expression (Fig. 6A).  Irx4 siRNA alone did not affect the 
basal promoter activity.  This might be due to very low levels of Irx5 in neonatal myocytes 
(unpublished observation).  A control siRNA produced no apparent effects on the Irx5-induced 
decrease in Kv4.2 promoter activity (Fig. 6B).  In contrast, the two Irx4 siRNAs resulted in a 
reduction in the Irx5-induced inhibition of the channel promoter.  At the higher dose of Irx4 
siRNA, Irx5 even caused a small increase in channel promoter activity.  Although it was unable 
to determine the level of Irx4 proteins in neonatal myocytes due to inability of the current 
commercially available anti-Irx4 antibody, the reduction and further increase in channel 
promoter activity were correlated with the efficacy of the two siRNAs to decrease Irx4 
expression in a mammalian cell line (Fig. 6A).  These results suggest that endogenous Irx4 
prevents the ability of transfected Irx5 to increase Kv4.2 promoter activity. 
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Figure 6.  Irx4 siRNA reverses the Irx5-induced regulation from inhibition to activation in neonatal 
myocytes. 
 (A) HEK293 cells were transfected with Flag-Irx4, GFP-C1 and indicated siRNA.  Immunoblot analysis was 
performed with anti-Flag and anti-GFP antibodies.  (B) Neonatal myocytes were transfected with Kv4.2-luciferase, 
pRL-tk, Irx5 or empty vector (None) and indicated amounts of siRNA. 
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2.5 DISCUSSION 
This chapter examined expression patterns of Irx members in various regions of the adult 
rat heart and their roles in controlling transcription of Kv4.2 channel gene.  The two Irx 
members, Irx3 and Irx5, are distributed in an inverse relationship to Kv4.2 gene across the left 
ventricular wall, whereas Irx4 is equally abundant throughout the ventricular tissues.  Only Irx5 
appears to possess the ability to control Kv4.2 gene promoter by itself.  Irx4 indirectly regulates 
the channel gene transcription by influencing the action of Irx5.  Thus, the interaction of the two 
Irx transcription factors plays an essential role in maintaining the transmural gradient of Kv4.2 
gene expression in rodent heart.  
Homeobox transcription factors are generally characterized by their fundamental roles in 
organogenesis and pattern formations during development.  Relatively less is known about their 
functions in adult organisms.  Yet, the expression of Irx genes is not transient in the developing 
embryos, but remains significant into adulthood.  For instance, Irx3 acts as a critical factor for 
patterning the intermediate region of the developing frog nephron, and remains segmentally in 
the mature nephron (51).  Likewise, previous and present study all show that Irx4 is required for 
ventricle-specific gene expression and is abundant in these chambers of adult hearts (26).  The 
data in this chapter further demonstrated that Irx4 and Irx5 possess the ability to control cardiac 
Kv4.2 gene transcription.  These findings indicate that Iroquois homeobox genes are not just 
reminiscent of embryonic development, but subsequently impose their effects on gene expression 
as maintenance factors in adult organs.    
Previous studies have suggested overlapping expression patterns of Iroquois proteins.  
The identical expression pattern of Ara and Caup is observed in Drosophila (52).  The 
overlapping expression of Irx1 and Irx2 is also seen in a subset of ventricular cells on the left of 
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the interventricular groove in the developing mouse heart (26).  Similarly, this study identified 
overlapping expression of Irx3, Irx4 and Irx5 in the rat left ventricle.  Furthermore, the two Irx 
members, Irx3 and Irx5, are similarly distributed in a gradient across the left ventricular wall.  
The presence of highly conserved non-coding elements in the Irx clusters is likely to contribute 
to the expression pattern of Irx proteins (Fig. 7).  In human and mouse genomes, the cluster A 
contains Irx1, Irx2 and Irx4, whereas the cluster B includes Irx3, Irx5 and Irx6.  It has been 
proposed that these two clusters derive from a chromosomal duplication event.  Shared 
enhancers present in the cluster B may contribute to the identical expression pattern of Irx3 and 
Irx5 in the left ventricle.  
Despite the overlapping expression patterns of Irx proteins, it is noteworthy that Irx 
members play distinct roles in controlling transcription of a subset of genes.  For example, a 
previous study reported distinct functions of Irx1 and Irx3 during Xenopus kidney development 
(53).  In this study, Irx5, but not Irx3, is found to regulate transcription of Kv4.2 gene.  The 
differentially-expressed Irx3 may regulate the expression of other, unidentified downstream 
genes.  In addition, Irx5 and Irx4 possess distinct functions in controlling Kv4.2 gene 
transcription.  These unique functional roles of individual Irx proteins are quite different from 
transcription factors in other families.  For example, GATA transcription factors often exhibit 
redundant functions (54-56).  Six mammalian Irx proteins contain substantially diverse N- and 
C-terminal regions (Fig. 7, alignment of rat Irx3, Irx4 and Irx5).  Thus, this diversity may 
provide a unique transcriptional regulatory role for each Irx transcription factor.   
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 Figure 7.   Genomic organization of Iroquois homeobox genes and alignment of the predicted amino 
acid sequence of rat Irx3, Irx4 and Irx5. 
 (A). Similar genomic organization of Irx genes in human and mouse.  Two clusters of three Irx genes are located in 
the indicated chromosomes. Orientation of arrows represents direction of transcription.  (B). Alignment of the 
predicted amino acid sequence of rat Irx3 (GenBank Accession No.XM_226322), rat Irx4 (GenBank Accession No.  
AF124732) and rat Irx5 (GenBank Accession No.  DQ109812).  Identical (*) and similar (·) residues are indicated 
underneath the sequence.  The homeodomain and IRO box are boxed. 
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One intriguing aspect of this study is the cell-type specific activity of Irx5 in regulating 
Kv4.2 gene promoter.  In 10T1/2 fibroblasts, Irx5 acts as a transcription activator.  A similar 
stimulation of the channel promoter was seen in Ad293, CHO and PC12 cells (unpublished 
observation).  In contrast, Irx5 inhibits the channel promoter in neonatal ventricular myocytes.  
The simplest interpretation of this observation is the presence of cardiac myocytes-specific 
factor(s) that alter the outcome of Irx5 action.  This study suggested that Irx4 is a plausible 
candidate for this role.  Irx4 is abundantly and restrictedly expressed in the ventricle of heart and 
known for regulating the chamber-specific gene expression (26, 27, 29).  Furthermore, Irx4 was 
found to inhibit the Irx5 effect on channel promoter in 10T1/2 cells.  A similar repressor action 
of Irx4 has been seen in other systems.  For example, retroviral vector-mediated expression of 
Irx4 specifically inhibits the expression of Slit1 gene in certain cell populations in retina (57), 
though the precise mechanism of this Irx4 action remains obscure.  Irx4 has also been shown to 
inhibit transcription of the gene for the atrial isoform of myosin heavy chain (29).  In this latter 
regulation, Irx4 appears to exert its effect indirectly by binding to other transcription factors.  
The observed Irx4 action on Kv4.2 promoter in this study is similar to this effect, in which Irx4 
itself produces no apparent effect on the channel promoter, but prevents the Irx5-induced 
increase.  Moreover, siRNA-mediated reduction in Irx4 caused an increase in channel promoter 
activity in cardiac myocytes.  These findings support the universal transcription activator action 
of Irx5 on Kv4.2 promoter in any cell types in the absence of Irx4.  Endogenous Irx4 mRNA was 
detected at a relatively high level in the culture of neonatal myocytes.  Therefore, the findings 
also suggest that abundant Irx4 may mask this activator role of Irx5 in myocytes. 
However, the identified Irx4-mediated suppression of the Irx5-induced activation is 
insufficient to account for the inhibitory effect of Irx5 on Kv4.2 promoter in myocytes.  First, 
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Irx5 at lower doses caused a marked reduction in channel promoter activity in myocytes.  
Second, coexpression of Irx4 and Irx5 at any ratio failed to lower channel promoter activity 
below the baseline in 10T1/2 cells.  Therefore, Irx5 might produce the inhibition of channel 
promoter in myocytes independent of its activator action.  It is conceivable that Irx5 possesses 
the ability to prevent the effect of unidentified myocyte-specific transcription activator.  This 
may be analogous to the Irx4 action on the atrial myosin heavy chain gene in which Irx4 blocks 
the activation by retinoic receptors and PXPR.  Further studies on identification of this putative 
myocyte-specific activator may be necessary for elucidating the region-selective expression of 
Kv4.2 gene in the heart.   
 
 45 
    3.0  THE REGULATORY MECHANISM BY WHICH IRX5 AND IRX4 CONTROL 
TRANSCRIPTION OF THE RAT KV4.2 GENE 
3.1 ABSTRACT 
The Iroquois (Irx) homeobox genes encode a conserved family of transcription factors 
that contain an atypical homeodomain with a three-amino acid extension.  Irx proteins have been 
shown to play important roles in diverse developmental processes.  Yet, little is known about 
their direct targets or regulatory mechanisms.  The previous chapter established that Irx5 inhibits 
Kv4.2 gene promoter in neonatal ventricular myocytes, whereas the transcription factor 
stimulates the channel promoter in non-myocytes.  Moreover, Irx4 appears to prevent this Irx5-
induced regulation of channel promoter.  This chapter is aimed at elucidating molecular 
mechanisms underlying these actions of the two Irx transcription factors on Kv4.2 promoter.  
Reporter gene assays using chimeras between Irx proteins show that the C-terminal region of 
Irx5 is necessary and sufficient for the regulation of channel promoter activity in both myocytes 
and non-myocytes.  This region also confers the repression by Irx4 of the promoter activity in 
non-myocytes.  Similarly, the N-terminal region of Irx4 is necessary and sufficient to suppress 
the regulation of promoter activity by Irx5.  Dimer formation was supported by co-
immunoprecipitation.  However an in vivo interaction system (Checkmate Mammalian Two-
hybrid System) failed to detect any interaction between Irx4 and Irx5.  Addition of histone 
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deacetylase inhibitor (TSA) relieved the inhibitory effect of Irx4 suggesting the involvement of 
HDACs in the Irx4-mediated inhibition of promoter activity.  These results indicate that diverse 
N- and C-terminal regions of Irx5 and Irx4 mediate their distinct actions on Kv4.2 gene 
promoter.  These actions of Irx proteins may involve indirect influences on other transcription 
factors and recruitment of genome-modifying enzymes.  
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3.2 INTRODUCTION 
Iroquois (Irx) proteins contain a highly conserved atypical homeodomain flanked by 
diverse N-terminal and C-terminal peptides, each with 100-150 amino acids and ~300 amino 
acids in length.  Unlike classic homeodomain proteins, such as Hox transcription factors, which 
have a characteristic 60-amino acid homeodomain, the atypical homeodomain of Irx proteins 
includes three extra amino acids between the helix 1 and helix 2, which places the Irx proteins 
into a subfamily, called TALE ( three amino acid loop extension) (37).  There are four classes of 
TALE proteins in vertebrates: PBC (58), MEIS (59), TGIF (60) and IRO corresponding to Irx 
proteins (52).  TALE proteins are also found in other organisms: two groups in fungi, the mating 
type genes (M-ATYP) and the CUP genes (37); two types in plant, maize Knotted-1 (61) and 
BEL (62).  This classification is mainly based on either sequence identity within the atypical 
homeodomain or conserved protein motifs outside of the atypical homeodomain.  Irx proteins 
have a conserved thirteen-amino acid domain, called the Iro box, in the C-terminal region (63), 
although no function has been assigned to this domain.  In addition, the atypical homeodomain 
of Irx proteins possesses additional unique characteristics, such as the presence of an alanine in 
the position that is occupied by a polar residue in the typical homeodomain (37).  These unique 
characteristics suggest that the DNA binding of Irx proteins is weaker than that of typical 
homeodomain proteins.  It also implies that the DNA-binding specificity of Irx proteins may be 
partially compensated for by interaction with other proteins through their N-terminal and C-
terminal regions.  Recently, the DNA binding of the Irx’s atypical homeodomain has been 
studied with the motif of the Drosophila Irx proteins, Mirror, using in vitro site selection.  This 
biochemical study showed that the binding sequence of the atypical homeodomain is 
substantially different from the classic Hox consensus (50).  Also the sequence outside the 
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identified core binding region affects the binding specificity.  Thus, the target DNA-binding site 
of Irx proteins remains obscure and may be largely influenced by their interacting proteins.  
One class of interacting proteins for the TALE-family proteins is the Hox proteins, the 
founding members of the homeodomain superfamily.  Indeed, the role of TALE atypical 
homeodomain proteins as co-factors for typical homeodomain transcription factors has been 
documented for a long time.  For example, the Pbx/exd atypical homeodomain proteins appear to 
influence the Hox developmental programs in arthropods and vertebrates (64).  Although these 
Hox proteins possess a similar sequence preference for DNA binding as monomers in vitro (65, 
66), they exhibit distinct target specificities when directing the developmental pathway in vivo 
(67).  A number of studies have suggested that this diversity is dependent on the presence of 
various cofactors including atypical homeodomain-containing proteins (64, 68).  The result of 
this protein-protein interaction is the enhanced DNA-binding affinity or specificity in vitro (69-
74).  Similarly, a recent gain-of-function study of Irx3 showed that Irx3 acts as a transcriptional 
regulator of Nkx6.1 and Nkx2.2, two typical homeodomain proteins, in ventral neuronal 
patterning in Drosophila embryo (42).  
The interaction between different TALE atypical homeodomain proteins has also been 
documented.  This heteromeric association confers strong binding to DNA sites for which the 
single protein shows otherwise weak affinity.  For example, Pbx proteins dimerize with Meis-hth 
and bind to a DNA element with a high affinity (75, 76).  This interaction also promotes nuclear 
localization and stability of Pbx proteins (77-81).  In addition, the formation of homodimers and 
heterodimers between Irx proteins has been suggested by an in vitro study (50).   
In addition to typical and atypical homeodomain-containing proteins, TALE 
homeodomain proteins also interact with non-homeodomain proteins, such as nuclear hormone-
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receptors (29).  Irx4 interacts with retinoic X receptor and forms a trimeric complex with 
Vitamin D receptor to bind to the vitamin D response element.  Another example is the 
repression of general transcriptional activators, such as Sp1 and E2F, by Irx3 in controlling 
neuronal gene expression (82).  Irx5 has also been suggested to interact with the muscle-specific 
transcription factor, mBOP, in regulating Kv4.2 gene transcription in mouse cardiac myocytes 
(2).  Taken together, TALE-family members including Irx proteins interact with a variety of 
factors to exert their effects on gene transcription.   
It has been speculated that the N-terminal region of Irx proteins is essential for protein-
protein interaction.  Gel shift assays showed that the flag-tagged Mirr protein that lacks the N-
terminal peptide fails to form a homodimer in the context of DNA-protein binding (50).  Another 
study using reporter gene assays indicated the importance of the N-terminal peptide of Irx4 in 
mediating the inhibition of the atrial myosin heavy chain gene.  This inhibition is believed to 
function through the interaction of Irx4 with the retinoic X receptor, suggesting the interaction of 
Irx4 N-terminal peptide with this hormone receptor (29).  On the other hand, a study using 
coimmunoprecipitation suggested that the C-terminal region of Irx5 is required for its association 
with mBOP, a muscle-specific transcription factor, in mediating its transcriptional regulation (2).  
Therefore, Irx proteins may control gene transcription by their interaction with other proteins via 
its N- and/or C-terminal regions.   
Finally, much progress has been made in the link between chromatin modifications and 
transcriptional regulation.  Chromatin modifications provide a coarse adjustment to gene 
expression by making a region of DNA more or less available for transcription.  Acetylation of 
the amino-termini of core histones has been shown to generate the formation of transcriptionally-
competent chromatin.  Histone deacetylation at the promoter region was generally shown to 
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correlate with impaired gene expression.  DNA methylation is another well-known mechanism 
for silencing genes.  For example, the methylation of CpG island near a promoter is known to 
silence certain genes in cancer (83).  A previous study suggested the involvement of histone 
deacetylases (HDACs) in mediating the repressor activity of Irx5 in controlling Kv4.2 gene 
expression in cardiac myocytes (2).  Thus, the regulation of channel gene transcription by Irx4 
and Irx5 may involve chromatin modifications. 
Hence, this chapter is to elucidate molecular mechanisms underlying Irx-mediated 
regulation of Kv4.2 gene promoter.  Various regions of Irx5 and Irx4 polypeptides were 
examined for their roles in channel gene transcription and the association between Irx proteins 
was examined by different assays.  This chapter also tested if the Irx-mediated regulation of gene 
transcription involves chromatin modifications. 
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3.3 MATERIALS AND METHODS 
3.3.1     Cell Culture and Reagents 
3.3.1.1   10T1/2 Cells 
10T1/2 cells were grown at 37ºC under 5% CO2 atmosphere in Basal Medium Eagle 
(BME) (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS) (Hyclone, 
Logan, UT) and 1% L-glutamine (Invitrogen, Carlsbad, CA).  Cells were passed just before 
confluence.  
3.3.1.2   Reagents 
            Trichostatin A (TSA) and RG108 were purchased from EMD Chemicals, Inc. 
(Calibochem, Gibbstown, NJ).  Stock solutions for these reagents were made in dimethyl 
sulfoxide (DMSO) at 1000-fold of the final working concentrations. 
3.3.2     Constructions 
3.3.2.1   Chimeras between Irx cDNAs 
Rat Ix3, Irx4, Irx5-pcDNA3 constructs were generated as described in the previous 
chapter.  Chimeras between two Irx cDNAs were generated by overlapped PCR or introduction 
of a unique restriction enzyme site near the border.  N, H and C in these chimeras denote the N-
terminal, homeobox and C-terminal peptides of Irx proteins, respectively: 3N, 3H and 3C 
indicate Irx3 polypeptides corresponding to the amino acid 1-134, 135-199 and 200-507; 4N, 4H 
and 4C represent Irx4 polypeptides to the amino acid 1-147, 148-212 and 213-515; 5N, 5H and 
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5C are Irx5 polypeptides to the amino acid 1-116, 117-181 and 182-484.  All chimeras were 
made in pcDNA3.  The obtained chimeric constructs were verified by DNA sequencing.   
3.3.2.2     Vectors for rIrx4 and rIrx5 Interaction Assays 
The rIrx4 and rIrx5 cDNAs were cloned into pACT and pBIND vectors for the 
interaction assay in mammalian cells.  The full-length rIrx4 and rIrx5 fragments were obtained 
by PCR with primers each containing BglII and NheI restriction sites (Table 3), and cloned into 
the BamHI-XbaI site of pACT and pBIND vectors (Promega, Madison, WI).   
To increase the flexibility of the protein binding, the linker [(GlyGlySer)4: 
GGTGGATCAGGCGGATCAGGTGGCTCAGGTGGGATC) ] was added between rIrx4/5 
cDNA and pACT/pBIND vector.  This was done by inserting the double-stranded 
oligonucleotides corresponding to this linker (Table 3) at the BamHI-MluI site of the vectors, 
followed by cloning the full-length Irx4 and Irx5 fragments into these linker-containing vectors.   
Table 3.   Oligonucleotides Used in rIrx4 and rIrx5 Interaction Assay 
rIrx5 5’-CAGCTCAGATCTCCTACCCGCAGGGCTACTT-3’ 
5’-CTGACGTCTAGATGTCGGACATACCTTTC-3’ 
rIrx4 5’-CGCAGCAGATCTCCTACCCGCAGTTTGGAT-3’ 
5’-GCTGACGCTAGCTGCAGAAGGGTTTGCCACT-3’  
linker 5’phospho-GATCGGTGGATCAGGCGGATCAGGTGGCTCAGGTGGGATC 
CA-3’ 
5’ phosphor-CGCGTGGATCCCACCTGAGCCACCTGATCCGCCTGATCCA
CC-3’ 
3.3.3     Reporter Gene Assay 
3.3.3.1    Transfection of Plasmid DNAs into 10T1/2 Cells 
10T1/2 Cells were seeded on 6-well plates with 50% confluence.  Kv4.2 promoter (-
1094~ +592) -reporter gene, rIrx-pcDNA3, chimeras between two Irx cDNAs-pcDNA3 and 
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pRL-tk were transfected into 10T1/2 cells using Lipofectamine 2000 at 1 μg DNA: 2 μl 
transfection reagent ratio for 3 hours in the absence of serum.  The transfected cells were 
cultured in the complete medium for one more day before harvesting for luciferase assay. 
3.3.3.2      Luciferase Assay  
The transfected cells were harvested with ice-cold PBS by scraping with a plastic lifter 
after washing with the same solution.  The cell pellets were collected by centrifugation at 2000 
rpm for 1 minute followed by one more wash with ice-cold PBS.  The cells were lysed with 1 x 
passive lysis buffer provided by the dual-luciferase reporter assay system and the activities of the 
two different luciferases (firefly and renilla) were detected according to the manufacture’s 
instruction.  
3.3.4      Co-immunoprecipitation 
3.3.4.1     Transfection 
10T1/2 cells in a 100-mm plastic dish were transfected with 5 μg of Flag-Irx or empty 
vector and Myc-Irx5 cDNAs, as described above.   
3.3.4.2     Immunoprecipitation  
           One day after transfection, cells were collected with ice-cold PBS.  Cell lysate was 
prepared by suspending the collected cell pellet in 400 μl of lysis buffer containing 20 mM Tris-
HCl (pH 7.5), 1% Triton X-100, 0.2 M NaCl and 1 mM EDTA supplemented with protease 
inhibitor cocktails at ~5 mg protein/ml.  After centrifugation at 10000 g for 10 minutes, proteins 
were incubated with protein-G agarose, monoclonal anti-Flag M2 or anti-Myc antibody (2 μg) at 
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4ºC for 2 hours for immunoprecipitation.  The bound materials were collected by centrifugation 
and washed 4 times with the same ice-cold lysis solution.  Bound materials were eluted with 2x 
SDS sample buffer and analyzed by immunoblot analysis.   
3.3.4.3     Immunoblot Analysis 
           Samples were separated on a 10% SDS-polyacrylamide gel and transferred to 
nitrocellulose membrane.  The membrane was blocked with 5% nonfat dry milk in 1x PBS 
supplemented with 0.1% Tween 20 (PBST) overnight  at 4 ºC followed by probing with the same 
monoclonal anti-Flag or polyclonal anti-Myc antibodies at 4 ºC for 2 hours.  The membrane was 
washed with PBST followed by incubation with a horseradish-peroxidase conjugated secondary 
antibody at room temperature for 1 hour.  The membrane was washed 4 times with PBST and 
incubated with chemiluminescent reagents at room temperature for 1 minute.  
Chemiluminescence images were captured and analyzed using charged-coupled device camera-
based system.  
3.3.5     Checkmate Mammalian Two Hybrid System 
3.3.5.1     Method Description and Strategy 
Interaction between Irx proteins was analyzed using the Checkmate Mammalian Two-
Hybrid system (Promega, Madison, MI).  Two control transfections were routinely included in 
experiments: the VP16-fusion protein plus the non-fused GAL4 binding domain (provided by the 
empty pBIND plasmid); and GAL4-fusion protein plus the non-fused VP16 activation domain 
(provided by the empty pACT plasmid).  These two controls were included to exclude the 
possibility that the firefly luciferase production is due to an interaction of either one of the fusion 
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proteins with the non-fused VP16 or GAL4 domains.  One day after transfection, the cells were 
lysed, and dual luciferase activity was measured.  The signal of Renilla luciferase was used for 
normalization.   
3.3.5.2     Transfection and Reporter Gene Assay 
           10T1/2 cells seeded on 6-well plates were co-transfected with a pair of the GAL4 and 
VP16 fusion constructs, pRL-tk and pG5luc vector.  Dual luciferase assay was performed 24 
hours after transfection as described above.  
3.3.6    Chromatin Modification Studies 
10T1/2 cells were co-transfected with rKv4.2 promoter (-1094~ +592)-pGL3 basic, rIrx5-
pcDNA3 and/or rIrx4-pcDNA3 in serum-free medium for 3 hours as described above.  
Immediately after transfection, cells were exposed to drug treatment in the complete serum-
containing medium for 24 hours.  Treatment conditions included DMSO (control), TSA (10 nM) 
or RG108 (0.2 μM).  After treatment, cells were harvested and dual luciferase activity was 
performed.   
3.3.7    Statistical Analysis 
Each data value was obtained from a duplicate assay.  Data values from at least three 
independent experiments were used for statistical analysis.  Statistical comparison was 
performed by one-way ANOVA, followed by Bonferroni’s posthoc test with a significance level 
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of 0.05 or greater using Prism 5.0 (GraphPad Software, San Diego, CA).  Results are expressed 
as mean ± SEM.   
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3.4 RESULTS 
3.4.1     The C-terminal Region of Irx5 Mediates the Regulation of Kv4.2 Gene Promoter 
Irx proteins contain a highly conserved atypical homeodomain flanked by diverse N- and 
C-terminal peptides, each with 100-150 amino acids and ~300 amino acids in length.  To identify 
the region of Irx5 that mediates the regulation of Kv4.2 promoter, various chimeras between Irx3 
and Irx5 were generated (Fig. 8A).  In 10T1/2 cells, substituting the N-terminal region of Irx5 
with the corresponding portion of Irx3 (3N-5HC and 3NH-5C) had no effect on the ability to 
increase channel promoter activity (Fig. 8B).  In contrast, replacing the C-terminal portion of 
Irx5 with that of Irx3 (5N-3HC and 5NH-3C) significantly and substantially reduced this 
induction.  Moreover, adding the C-terminal region of Irx5 to Irx3 (3N-5HC and 3NH-5C) 
transferred the ability to induce promoter activity.  In addition to the ability to induce channel 
promoter activity, the C-terminal portion of Irx5 conferred the suppression by Irx4: Irx4 reduced 
the upregulation caused by 3N-5HC and 3NH-5C, as well as the original Irx5.  Therefore, the C-
terminal region of Irx5 is necessary and sufficient for the induction of channel promoter and its 
suppression by Irx4 in these fibroblastic cells.  
The generated chimeras were also used to test if the C-terminal region of Irx5 might also 
be responsible for the reduction in channel promoter activity in neonatal ventricular myocytes 
(Fig. 9).  Chimeras containing the C-terminal region of Irx5 (3N-5HC and 3NH-5C) were 
capable of inhibiting channel promoter activity.  Substituting this region with the corresponding 
Irx3 peptide (5N-3HC and 5NH-3C) eliminated the ability to produce this inhibition, although 
the latter chimera tended to cause a small reduction in promoter activity.  Thus, the C-terminal 
region of Irx5 is mainly responsible for the inhibition of Kv4.2 promoter in neonatal myocytes.  
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Taken together, the C-terminal Irx5 peptide mediates the regulation of channel promoter activity 
in both myocytes and non-myocytes. 
 
Figure 8.   The C-terminal region of Irx5 mediates activation of Kv4.2 promoter in 10T1/2 cells. 
(A) Chimeras between Irx3 and Irx5 used for the study are shown with grey and black bars indicating regions 
originated from the former and latter, respectively.  N, H, and C represent N-terminal, homeobox and C-terminal 
portions, respectively.  (B) 10T1/2 cells were transfected with indicated individual or combination of wild-type or 
chimeric Irx proteins.  Total amount of expression vector was kept constant by supplementing empty vector.  *3N-
5HC, 3NH-5C and 5NH-3C, as well as Irx5, significantly increased Kv4.2 promoter activity compared to None or 
Irx3 (p<0.05, n>4 for each condition).  ‡However, the increase produced by 5N-3HC was significantly smaller than 
that by 3N-5HC, 3NH-5C or Irx5 (p<0.05).  #Coexpression of Irx4 significantly reduced the increase produced by 
3N-5HC, 3NH-5C, 5NH-3C or Irx5 (p<0.05). 
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Figure 9.   The C-terminal region of Irx5 confers the reduction in Kv4.2 promoter activity in 
neonatal ventricular myocytes. 
 (A) Chimeras between Irx3 and Irx5 used for the study are shown with grey and black bars indicating regions 
originated from the former and latter, respectively.  N, H, and C represent N-terminal, homeobox and C-terminal 
portions, respectively.  (B) Neonatal myocytes were transfected with indicated wild-type or chimeric Irx proteins.  
*3N-5HC, 3NH-5C and Irx5 significantly decreased Kv4.2 promoter activity compared to None or Irx3 (p<0.05, 
n=4 for each condition). 
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3.4.2     The N-terminal Region of Irx4 is Responsible for the Suppression of the Irx5-
induced Regulation 
The region of Irx4 responsible for the suppression of the Irx5-induced regulation was 
next examined using various chimeras between Irx3 and Irx4 (Fig. 10A).  These chimeras, as 
well as the original Irx3 and Irx4, produced only minor changes in Kv4.2 promoter activity by 
themselves (Fig. 10B).  Substitution of the N-terminal portion of Irx4 with the corresponding 
region of Irx3 (3N-4HC and 3NH-4C) disrupted the inhibition of the Irx5-induced increase in 
promoter activity.  Furthermore, addition of the N-terminal region of Irx4 to the corresponding 
portion of Irx3 (4N-3HC and 4NH-3C) exhibited the suppression of Irx5-induced activation.  
Hence, the N-terminal region of Irx4 is necessary and sufficient for the suppression of the Irx5-
induced increase in Kv4.2 promoter activity. 
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 Figure 10.   The N-terminal region of Irx4 mediates the suppression of the Irx5-induced activation of 
Kv4.2 promoter. 
 (A) Chimeras between Irx3 and Irx4 used for the study are shown with grey and black bars indicating regions 
originated from the former and latter, respectively.  N, H, and C represent N-terminal, homeobox and C-terminal 
domains, respectively.  (B) 10T1/2 cells were transfected with indicated individual or combination of wild-type or 
chimeric Irx proteins.  *4N-3HC, 4NH-3C, as well as Irx4, significantly decreased the Irx5-induced activation of 
Kv4.2 promoter compared to None or Irx3: Irx5 + 4N-3HC, Irx5 + 4NH-3C or Irx5 + Irx4 < Irx5 or Irx5 + Irx3 
(p<0.05, n=4 for each condition). 
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3.4.3     Iroquois Proteins Less Efficiently Form Homomeric and Heteromeric Complexes 
In Vitro 
To test if the observed suppression by Irx4 might be due to its selective association with 
Irx5, immunoprecipitation with N-terminally-tagged Irx proteins was performed (Fig. 11).  Irx5 
proteins interacted indiscriminately with Irx3 and Irx4, as well as its own kind.  However, the 
efficiency of complex formation seemed very low compared to the input Irx proteins.  Changing 
detergent concentrations or composition (0.2-1% Triton X-100 and 1% Triton X-100 + 0.1% 
SDS) or salt concentrations (0 to 0.5 M NaCl) did not affect the observed non-selective 
association or the efficiency.  These findings suggest that Irx members can form homomeric and 
heteromeric complexes albeit less efficiently.   
 To further verify the association of Irx4-Irx5 identified by co-immunoprecipitation of 
ectopically expressed Irx cDNAs, a mammalian two-hybrid system (Checkmate Mammalian 
Two-hybrid System, Promega) was employed to test this putative interaction.  The entire Irx5 
and Irx4 proteins were cloned into the two-hybrid plasmids pACT and pBIND and luciferase 
reporter gene (pG5) assay was performed 24 hours after transfection.  However, no significant 
association was observed between Irx5 and Irx4 fusion proteins (Fig. 12A and B).  To enhance 
the sensitivity of the two-hybrid system, a flexible linker with twelve amino acids (GlyGlySer)4 
between reporter domains and Irx polypeptides was introduced.  Again, no detectable interaction 
between the two Iroquois proteins was detected (Fig. 12C and D).       
The homodimerization between the same Irx proteins was also examined using the two-
hybrid system.  When Irx5-pBIND construct was co-transfected with their homologous VP16-
tagged construct, a significant (~3 fold) transcriptional activation resulting from the formation of 
homomeric complexes of Irx5 proteins was observed (Fig. 13A).  However, no interaction 
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between Irx4-GAL4 or Irx4-VP16 fusion proteins was detected (Fig. 13B).  Therefore, Irx5, but 
not Irx4, proteins can form homomeric complexes under this assay condition. 
Taken together, we failed to observe consistent complex formation between Irx proteins.  
The discrepancy between immunoprecipitation and two-hybrid assays might be due to the lack of 
nucleus localization of putative complexes (i.e. Irx4-Irx4 and Irx4-Irx5) or the introduction of a 
large reporter polypeptide at the N-terminus of Irx proteins.  Importantly, the selective 
suppression of the Irx5-induced promoter activation by Irx4 is not due to its specific physical 
interaction. 
 
Figure 11.   Iroquois proteins form homodimers and heterodimers in vitro. 
10T1/2 cells were transfected with Myc-Irx5 and indicated Flag-Irx or empty vector.  Extract was prepared with 1% 
Triton X-100 and immunoprecipitation was performed anti-Flag antibody.  Extract and immunoprecipitate (anti-Flag 
IP) were subjected to immunoblot analysis.  Arrow heads indicate the position of indicated proteins.  IgGH and 
IgGL represent IgG heavy and light chains, respectively. 
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 Figure 12.   No interaction was detected between Irx5-Irx4 in a mammalian two-hybrid system. 
Rat Irx cDNA were fused to VP16 activation domain or GAL4 DNA-binding domain as described in Materials and 
Methods.  10T1/2 cells were co-transfected with a pair of the indicated constructs, pG5 (None) and pRL-tk 
(Normalization).  Hyphens indicate the expression of an unfused VP16 or GAL4 protein.  Columns indicate the 
mean of luciferase activity relative to None (pG5 only) with error bars representing S.E.M. (n=3 for Fig. A, C; n=4 
for Fig. B, D). 
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 Figure 13.    Irx5, but not Irx4 forms homomeric complexes in a mammalian two-hybrid system. 
Rat Irx cDNA were fused to VP16 activation domain or GAL4 DNA-binding domain as described in Materials and 
Methods.  10T1/2 cells were co-transfected with a pair of the indicated constructs, pG5 (None) and pRL-tk 
(Normalization).  Hyphens indicate the expression of an unfused VP16 or GAL4 protein.  Columns indicate the 
mean of luciferase activity relative to None (pG5 only) with error bars representing S.E.M. (n=3 for Fig. A; n=5 for 
Fig. B). 
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3.4.4     Histone Deacetylase Inhibitor Relieves the Inhibition of Irx5 Effect by Irx4 
           It is known that the degrees of histone acetylation and/or DNA methylation in the 
promoter region of gene influence the transcription initiation.  It has also been proposed by 
Costantini DL et al., that the recruitment of histone deacetylases (HDACs) is involved in the 
action of Irx5 on Kv4.2 promoter activity (2).  To investigate whether the observed Irx5 and Irx4 
effects on the promoter activity of Kv4.2 gene occur via histone acetylation or DNA methylation,  
transfected cells were treated with 10 nM HDAC inhibitor Trichostatin A (TSA) (Fig. 14B), 0.2 
μM DNA methyltransferase inhibitor (RG108) (Fig. 14A), or vehicle control for 24 hours before 
luciferase assay.  Addition of TSA or RG108 did not significantly change the Irx5-induced 
increase in promoter activity.  In contrast, TSA, but not RG108, relieved the inhibition by Irx4.  
These suggest that Irx4 recruits HDACs to suppress the Irx5-mediated activation of channel 
promoter.    
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 Figure 14.    Histone deacetylase inhibitor relieves the inhibition of Irx5-induced activation by Irx4. 
10T1/2 cells were co-transfected with a luciferase reporter gene vector (pGL3-basic) containing rKv4.2 promoter (-
1094~ +592), rIrx5 and/or Irx4, and pRL-tk in a serum-free medium for 3 hours as described in Methods and 
Materials.  The empty vector pCDNA3 was used to keep the total amount of DNA constructs constant.  The 
transfected cells were then changed to complete medium containing DMSO (control), TSA (10 nM) (B) or RG108 
(0.2 μM) (A) for 24 hours before harvest for luciferase assay. Irx4 significantly inhibited the promoter activity 
induced by Irx5 in DMSO and RG108 (* p<0.05, ** p<0.01, *** p<0.005, n=3).  Note there is no significant 
inhibition of the Kv4.2 promoter by Irx4 in TSA (n=8). 
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3.5 DISCUSSION 
Homeodomains are generally considered to act as a DNA-binding motif.  However, a 
number of studies have suggested Iroquois (Irx) proteins possess a weaker DNA-binding affinity 
or produce its transcriptional regulation indirectly by interacting with other transcription factors.  
The present study using various chimeras between Irx proteins revealed that the unique N- and 
C-terminal peptides of Irx proteins are necessary and sufficient for the regulation of Kv4.2 
channel promoter.  The C-terminal peptide of Irx5 mediates the upregulation of channel 
promoter, whereas this enhancement is suppressed by the N-terminal portion of Irx4.  Taken 
together with the extremely high conservation of atypical homeodomains in Irx members, these 
findings support the possibility that the Irx proteins control Kv4.2 promoter by influencing other 
transcription factors.   
A previous study suggests that Irx proteins may form homomeric or heteromeric 
complexes in vitro (50).  In this study, the physical interactions between Irx proteins were 
examined with co-immunoprecipitation and two-hybrid system.  While the former detected non-
selective interactions between any two Irx members, the latter detected homomeric association of 
Irx5, but not complexes between Irx4 and Irx5.  This discrepancy might arise from a number of 
reasons.  First, the two-hybrid system uses addition of a relatively large peptide at the N-
terminus of the bait.  Potentially, it prevents the formation of Irx-Irx complexes.  However, the 
positive association of Irx5 homomeric complexes argues against this possibility.  Moreover, the 
introduction of a flexible linker also failed to detect Irx4-Irx5 heteromeric complexes.  Another 
possibility is that the two-hybrid system is based on transcriptional activity and thus requires 
nuclear localization of the newly formed complexes.  Therefore, if Irx4-Irx5 complexes are only 
formed in cytosol and fail to import to the nucleus, then the assay would yield a negative result.  
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This possibility is supported by the fact that Irx4-VP16 appears to give lower firefly signal in this 
system compared with Irx5-VP16.  Thus, Irx4 may be less efficiently imported to or more 
efficiently exported from the nucleus.  Future studies on subcellular localization of Irx 
complexes may be required to solve this issue. 
It has been observed that TGIF2, a TALE atypical homeodomain protein, represses gene 
transcription at least in part by recruiting histone deacetylase 1 (HDAC1) (84).  To test the 
involvement of chromatin modification in the Irx4-mediated transcriptional repression, the 
histone deacetylase inhibitor TSA and the DNA methyltransferase inhibitor RG108 were used in 
this study.  Unlike sodium butyrate that elicits pleiotropic effects, TSA is thought to specifically 
inhibit histone deacetylase activity (85).  TSA significantly counteracted the repression elicited 
by Irx4, whereas RG108 did not affect the repression activity of Irx4.  These suggest the 
participation of HDAC in the Irx4-mediated inhibitory effect.  The same observation was made 
by Costantini DL et al. in dissecting the regulatory mechanism of Irx5 on the Kv4.2 expression, 
although the proposed co-repressor was different (2).  They postulated that HDACs was recruited 
by mBOP to repress the transcription of Kv4.2 channel gene.  To address the question whether 
HDACs are associated on the promoter region (-1094~ +592) of Kv4.2 gene, other approaches 
for a direct detection such as chromatin immunoprecipitation may be required.   
The N-terminal region of Iroquois proteins is proposed to act as a protein interaction 
domain.  In vitro translation of flag-Mirr, a fly Irx protein, lacking the N-terminal peptide failed 
to form homodimer in a pull-down assay (50).  However, since deletion might result in 
misfolding of truncated proteins, one can argue that the failure of homodimerization with N-
terminal truncation may arise from impaired conformation of the protein.  Another study using 
CAT reporter gene assay showed the importance of the N-terminal region of Irx4 in mediating 
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the inhibitory effects on transcription of the atrium-specific myosin heavy chain gene (29).  
Concordantly, the N-terminal region was identified to interact with retinoic X receptor α subunit 
(29).  Analysis with chimeric Irx proteins in this study also revealed the importance of the N-
terminal region of Irx4 in the suppression of Irx5-induced activation of Kv4.2 promoter.  Taken 
together, these results support a model where Irx4 interacts with an as yet identified molecule via 
its N-terminal region to inhibit channel gene transcription.  Since the suppression by Irx4 was 
prevented by inhibition of histone deacetylase, the putative Irx4-containing complexes may 
involve these enzymes.   
While this work, as well as several previous studies (29, 50), indicates that the N-terminal 
region of Irx proteins interact with cofactors, little is known about the roles of their C-terminal 
peptides.  The C-terminal region of Irx proteins contains a 13-amino-acid homology domain, 
named the Iro box.  Outside the Iro box, the similarity in amino acid sequence is very low.  The 
study by Costantini et al. suggests that the region proximal to the atypical homeodomain of Irx5 
is required for its regulation of Kv4.2 promoter (2).  The chimera analysis in this chapter also 
demonstrated that the entire C-terminal region of Irx5 is necessary and sufficient for the 
regulation of channel promoter.  Moreover, the same region confers the inhibitory effect by Irx4.  
Thus, the C-terminal peptide of Irx5 may also recruit cofactors to activate transcription of the 
Kv4.2 gene.  Irx4 may prevent the Irx5’s complex formation with this putative cofactor or its 
activity.   
The structure-function studies in this chapter suggest that Irx proteins interact with 
various cofactors via diverse N- and C-terminal peptides to control gene transcription.  The 
presence and absence of these cofactors likely underlie the observed cell type-specific and 
region-selective expression of Kv4.2 gene.  Given the high homology of the DNA-binding 
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atypical homeodomain in Irx proteins, it is plausible that they require cofactors to achieve their 
diverse biological functions.  Incorporation of these cofactors may enhance DNA-binding 
specificity or stability, or even alter the outcome of the DNA binding, as has been seen with 
typical homeodomain transcription factors.  Hence, the observations made in this study and 
previous reports by others support the proposal that heteromeric complex formation of TALE 
atypical homeodomain proteins including Irx proteins with homeodomain-containing and/or 
other factors may be a generalized feature of their transcriptional functions. 
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      4.0  THE CIS-ELEMENT REQUIRED FOR THE IRX5-INDUCED RAT KV4.2 GENE 
TRANSCRIPTION 
4.1 ABSTRACT 
Iroquois (Irx) proteins are transcription factors with an atypical homeodomain.  However, 
their target genes and binding sequences remain largely unknown.  A previous animal study (2) 
and previous chapters in this thesis have demonstrated the importance of Irx5 in regulating 
Kv4.2 gene transcription.  This chapter uses deletion and mutation analyses of the channel 
promoter, and electromobility shift assays to identify Irx5-regulatory elements.  Deletion 
analysis of the Kv4.2 5’flanking region indicated that multiple regions between -1002 and -414 
are required for the full activation of channel promoter by Irx5 in 10T1/2 cells.  The most 
dramatic reduction of Irx5-mediated activation was seen when a 36-bp portion (-1002~ -966) 
was eliminated.  The 5’flanking region also activated a minimum heterologous promoter (SV40) 
in response to Irx5 in a direction-dependent way.  Similarly, the 36-bp fragment is sufficient to 
mediate the Irx5 response in a direction-dependent manner.  Point mutations further identified a 
GT-rich element (GGTGGGTGG) in this 36-bp region that is required for the activation by Irx5.  
Electrophoretic mobility shift assay (EMSA) failed to detect any specific binding of Irx5 in this 
region, but suggested a binding of an unidentified endogenous protein in fibroblast cells.  In 
conclusion, these results demonstrate the presence of a previously unidentified Irx5-response 
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element in the Kv4.2 distant promoter region.  They also suggest that Irx5 indirectly regulates 
Kv4.2 gene transcription by influencing other factors that control channel promoter activity.   
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4.2 INTRODUCTION 
  Iroquois (Irx) proteins possess a 63-amino acid atypical homeodomain with three extra 
amino acids (proline-tyrosine-proline) between the helix 1 and helix 2.  This insertion is found in 
various transcription factors, which constitute the TALE atypical homeodomain superclass (37).  
The DNA-binding specificity of homeodomain is primarily determined by its third helix, called 
the recognition helix, which inserts itself into the major groove of the recognition site (86, 87).  It 
has been proposed that the 9th position of the recognition helix (the 50th position of the 
homeodomain) plays a critical role in differential DNA recognition (88, 89).  In most cases, 
homeodomain proteins have a polar residue at the 50th position, such as glutamine, lysine, 
cystein, histidine or serine.  In contrast, proteins in the TALE atypical homeodomain superclass 
invariably contain a non-polar residue, isoleucine, with the exception of alanine in Irx proteins 
and glycine in Pbx proteins (37).   
Much of knowledge about the DNA recognition sites for homeodomain proteins come 
from studies of classic homeodomains.  These typical homeodomains bind to the sequence 
consisting of the common “TAAT” core with additional two residues at the 3’ end which differ 
depending on individual homeodomain proteins (90).  Very little is known about the binding 
sites of the atypical homeodomains.  An early study found that the Drosophila Irx protein, 
Arauca, protected a region containing the classic consensus sequence, TAAT, in footprinting 
assays (52).  A later study examined the same region carefully and suggested a different binding 
site (ACAnnTGT) for the Drosophila Irx protein, Mirr, using in vitro site selection and 
electrophoretic mobility shift assays (EMSA) (50).  Another biochemical study suggested that 
TGIF (5’TG3’ Interacting Factor), a member of TALE atypical homeodomain proteins, binds to 
a TGTCA core sequence and represses retinoid X receptor α-mediated transcription activation as 
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competing overlapping DNA binding sites (60).  Thus, the binding sequence of Irx proteins 
remains obscure. 
The Irx5-mediated regulation of Kv4.2 gene promoter provides an excellent opportunity to 
identify cis element(s) that is required for transcriptional regulation by atypical homeodomain 
transcription factors.  A previous study in this laboratory using 5’ RACE and RNase protection 
assays have determined the transcription start site of Kv4.2 gene (36).  The transcription of this 
gene was found to initiate at 552 bp upstream from the translation site in the brain and heart.  
Approximately 200-bp fragment encompassing this transcription start site drives significant 
transcription in neonatal cardiac myocytes.  Nothing is known about the distant promoter region 
of Kv4.2 gene.  This study and reports by others (2) indicate that the region between -1073 and -
432 is required for the full activation of channel promoter by Irx5, suggesting the presence of 
Irx-responsive element(s) in this region.  Therefore, this chapter is aimed at identifying cis 
element(s) that mediate Irx5-induced regulation of Kv4.2 gene.  
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4.3 MATERIALS AND METHODS 
4.3.1     Cell Culture and Reagents 
4.3.1.1    Cell Culture 
10T1/2 cells were cultured as described in the previous chapters.  Ad293 human 
embryonic kidney epithelial cells were obtained from Stratagene (La Jolla, CA).  This cell line 
was derived directly from the HEK293 cells and possesses improved adherence to plastic dishes.  
These cells were cultured in DMEM supplemented with 10% FBS at 37ºC under 5% CO2 
atmosphere.   
   
4.3.1.2   Reagents 
Poly-(deoxyinosinic-deoxycytidylic) acid sodium salt was from Sigma-Aldrich (St. 
Louis, MO).  Ammonium persulfate and N,N,N’,N’-tetramethylethylenediamine (TEMED) were  
from Bio-Rad (Hercules, CA).   
4.3.2     Constructions 
4.3.2.1   Kv4.2 Promoter-pGL3 Basic Constructs 
Various 5’ deletion fragments of Kv4.2 5’flanking region were generated by PCR-based 
methods using primers with convenient restriction enzyme sites (Table 4 with restriction enzyme 
sites underlined).  These fragments were then subcloned into pCR-Blunt II TOPO vector 
(Invitrogen, Carlsbad, CA) and digested at the introduced enzymes sites to release the fragments, 
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followed by cloning the released fragments into the identical or compatible restriction enzyme 
sites in the polylinker of pGL3-basic vector.   
Table 4.  Primers Used in Deletion Analysis 
Constructs Forward Reverse  
-1002/ +488 5’- TTGGATCCATTTGGCGTC 
GAGGCTGG-3’ 
5’-AAGCTTCCCCACTTCTTC 
ACCTC-3’ 
-966/ +488 5’-GCTAGCGCGAGAGGAGCC 
CGA-3’ 
5’-AAGCTTCCCCACTTCTTC 
ACCTC-3’ 
-934/ +488 5’-GCTAGCAAGGTCAAGGCG 
AG-3’ 
5’-AAGCTTCCCCACTTCTTC 
ACCTC-3’ 
-906/ +488 5’-CAGGATCCGCCTTTGCCTA 
ACCTGC-3’ 
5’-AAGCTTCCCCACTTCTTC 
ACCTC-3’ 
-858/ +488 5’-CTGGATCCCTCCCTGCTTA 
TTTATCG-3’ 
5’-AAGCTTCCCCACTTCTTC 
ACCTC-3’ 
-547/ +488 5’-CGGGATCCCCGCACCTTTT 
TGAACTTG-3’ 
5’-AAGCTTCCCCACTTCTTC 
ACCTC-3’ 
-491/ +488 5’-CTGGATCCTGGGAAGGTG 
ACAAGGAG-3’ 
5’-AAGCTTCCCCACTTCTTC 
ACCTC-3’ 
-434/ +488 5’-GAGGATCCGCCAGAGCTT 
TATTTATGC-3’ 
5’-AAGCTTCCCCACTTCTTC 
ACCTC-3’ 
 
4.3.2.2    Kv4.2-SV40 Promoter Constructs  
            The effects of Kv4.2 5’ flanking region on a heterologous promoter were tested using 
pGL3-promoter vector which contains the multiple cloning sites in front of the SV40 minimum 
promoter.  Various lengths of the Kv4.2 5’flanking region were generated by PCR using primers 
with unique or convenient restriction enzyme sites (Table 5 with restriction enzyme sites 
underlined).  These fragments were subcloned into pCR-Blunt II TOPO vector and digested with 
appropriate restriction enzymes to release the inserts.  The released fragments were then cloned 
into the identical or compatible enzyme sites in the polylinker of pGL3-promoter vector. 
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Table 5.  Primers Used for Heterologous Promoter Assay 
Constructs Forward Reverse 
-1073bp~-98bp 
-1073bp~-98bp (R) 
5’- AAGCTTCCCTTTG 
TTCATCC-3’ 
5’-CGTCGGTCTAGAGTTCT 
CTG-3’ 
 
-1073bp~-572bp 5’-AAGCTTCCCTTTG 
TTCATCC-3’ 
5’-GCTCCTGCCAACTTACTG 
CG-3’ 
-867bp~-329bp 5’-CTGGATCCCTCCC 
TGCTTATTTATCG-3’ 
5’-GCATAGAGACTTTGCTGT
CG-3’ 
-1013bp~-903bp 5’-TCTCCCTTGGTGA 
CATTTGG-3’ 
5’-TCTCCTGCCTTTCCCTCG 
CC-3’ 
4.3.2.3   Kv4.2 (-1002~ -966) x1, x2 and x4-pGL3-promoter Vectors 
Heterologous promoter constructs containing the 36-bp (-1002~ -966) Kv4.2 5’flanking 
region were made in pGL3-promoter vector.  The 5’-end phosphorylated double-strand 
oligonucleotides corresponding to one or two copies of the 36-bp fragment were chemically 
synthesized (Table 6 with restriction enzyme sites underlined).  Because the fragment with two 
copies was very long, one (sense) strand with the full sequence and the other that corresponded 
to the 3’-end portion of the long oligonucleotide were used.  The two partially-compatible 
oligonucleotides were annealed and excessive end was filled by PCR.  This fill-in PCR protocol 
was: 10 PCR cycles consisting of 65ºC for 20 seconds and 72ºC for 20 seconds; followed by a 
final extension at 72ºC for 2 minutes.  The obtained blunt-ended fragment was cloned into the 
topoisomerase-based vector, pCR-Blunt TOPO II.   
The construct containing one 36-bp fragment [Kv4.2 (-1002~ -966) x1] was generated by 
a simple linker ligation, whereas the one with two fragments [Kv4.2 (-1002~ -966) x2] was made 
from the pCR-Blunt TOPO II containing two 36-bp fragments in tandem.  For the former, the 
two oligonucleotides contained sticky ends compatible to the BglII site at the 5’end and the NheI 
site at the 3’end.  Followed by annealing of the complementary oligonucleotides, the annealed 
oligonucleotides were inserted to the BglII-NheI site of pGL3-promoter.  For the latter, the insert 
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was liberated with BglII and NheI from the TOPO construct and subcloned into the 
corresponding site of the vector. 
The construct with four copies of the 36-bp fragment was then generated by inserting an 
additional two 36-bp-containing fragments into Kv4.2 (-1002~ -966) x2.  To provide the 
fragment with two 36-bp region suitable for subcloning, the TOPO clone with correct direction: 
KpnI-the insert-XbaI, was selected.  The insert was liberated from the TOPO clone with these 
two enzymes and subcloned in front of the two elements of Kv4.2 (-1002~ -966) x2 at the KpnI-
XbaI site.  The generated four 36-bp fragment-containing constructs have extra sequences 
between the front two and the back two 36-bp fragments. 
Table 6.  Oligomers Used for Construction of 36-bpx1, x2, x4-pGL3-promoter Vectors. 
Constructs    Forward Reverse 
36-bp x1 5’phospho-CTAGCATTTGGCGTC 
GAGGCTGGTGGGTGGCTAGGG
TGGA-3’ 
5’phospho-GATCTCCACCCTAGCCA 
CCCACCAGCCTCGACGCCAAATG-
3’ 
36-bp x2 
36-bp x4 
5’phospho-CATTTGGCGTCGAGG 
CTGGTGGGTGGCTAGGGTGGA
GATCCATTTGGCGTCGAGGCT
GGTGGGTGGCTAGGGTGGAAG
ATCTGATC-3’ 
5’phospho-GATCAGATCTTCCTCCC 
TAG-3’ 
4.3.2.4    Kv4.2-(-1002~ -966)-mutation-pGL3-promoter Vectors 
Kv4.2-(-1002~ -966)-mutation constructs contain four copies of the identified 36-bp 
region from -1002 to -966 with nucleotide substitutions eliminating the consensus for either an 
E-box motif   (5’-ACTTGTGCGTCGAGGCTGGTGGGTGGCTAGGGTGGA -3’)  
or a GT-rich motif (5’- CATTTGGCGTCGAGGCTGCAGGCAGGCTAGGGTGGA-3’).  
The four 36-bp elements with mutations were cloned upstream of the SV40 minimum promoter 
in pGL3-promoter vector.  These constructs were generated using simultaneous ligation of two 
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double-stranded oligonucleotides into a standard cloning vector, followed by transferring a two-
36-bp-containing fragment from the cloning vector to the pGL3-promoter vector with a two-
mutant 36-bp fragment.  Three sets of compatible oligonucleotides containing altered E-box or 
GT-rich motif with sticky ends (Table 7 with restriction enzyme sites underlined) were designed.  
The first set contained the 5’ NheI-compatible end and the 3’ HindIII-compatible end; the second 
the 5’ HindIII-compatible end and the 3’ XhoI-compatible end; and the third the 5’ HindIII-
compatible end and the 3’ BglII-compatible end.  The first and second sets of annealed 
oligonucleotides were simultaneously cloned into the SpeI-XhoI site of pCR-BluntTOPOII 
vector.  These clones were used to supply the fragment for a two-mutant-containing-36-bp 
region.  The first and third sets were similarly cloned into the NheI-BglII site of pGL3-promoter 
vector to generate intermediate constructs with two 36-bp fragments in a heterologous promoter 
vector.  The two 36-bp-containing fragments from the cloning vector were released by digestion 
with KpnI and XbaI in the polylinker region.  The released fragments were then cloned into the 
KpnI-NheI site of the intermediate constructs.  The inserts of the obtained constructs were 
verified by DNA sequencing. 
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Table 7.   Oligomers Used for Mutation Analysis 
Constructs Forward Reverse 
E-box mutation 5’phospho-
CTAGCACTTGTGCGT
CGAGGCTGGTGGGT
GGCTAGGGTGGA-3’ 
5’phospho-
AAGCTTCCACCCTAG
CCACCCACCAGCCTC
GACGCACAAGTG-3’ 
5’phospho-
AGCTTACTTGTGCGT
CGAGGCTGGTGGGT
GGCTAGGGTGGA-3’ 
5’phospho-
TCGATCCACCCTAGC
CACCCACCAGCCTCG
ACGCACAAGT-3’ 
5’phospho-
AGCTTACTTGTGCGT
CGAGGCTGGTGGGT
GGCTAGGGTGGA-3’ 
5’phospho-
GATCTCCACCCTAGC
CACCCACCAGCCTCG
ACGCACAAGT-3’ 
GT-rich mutation 5’phospho-
CTAGCCATTTGGCGT
CGAGGCTGCAGGCA
GGCTAGGGTGGA -3’ 
5’phospho-
AAGCTTCCACCCTAG
CCTGCCTGCAGCCTC
GACGCCAAATGG-3’ 
5’phospho-
AGCTTCATTTGGCGT
CGAGGCTGCAGGCA
GGCTAGGGTGGA-3’ 
5’phospho-
TCGATCCACCCTAGC
CTGCCTGCAGCCTCG
ACGCCAAATG-3’ 
5’phospho-
AGCTTCATTTGGCGT
CGAGGCTGCAGGCA
GGCTAGGGTGGA-3’ 
5’phospho-
GATCTCCACCCTAGC
CTGCCTGCAGCCTCG
ACGCCAAATG-3’ 
4.3.3     Reporter Gene Assay and Luciferase Assay 
10T1/2 cells were seeded on 6-well plates with 50% confluence.  Kv4.2 promoter-
reporter gene, pRL-tk, and rIrx5-pcDNA3 were co-transfected into 10T1/2 cells using 
Lipofectamine 2000 at 1 μg DNA: 2 μl transfection reagent ratio for 3 hours in the absence of 
serum.  The transfected cells were cultured in the complete medium for one more day before 
harvesting for luciferase assay as described above. 
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4.3.4      Electrophoretic Mobility Shift Assay (EMSA) 
4.3.4.1      Nuclear Extraction 
Ad293 cells in a 100-mm plastic dish were transfected with 5 μg of rIrx5-pcDNA3 or 
empty vector as described above.  One day after transfection, Ad293 cells were scraped off from 
plastic surface using a plastic lifter with ice-cold PBS.  The cell pellets were collected by 
centrifugation at 2000 rpm for 1 minute.  Nuclear proteins were prepared by using NE-PER 
nuclear and cytoplasmic extraction reagents (Pierce Perbio Science, Erembodegem, Belgium) 
according to the manufacturer’s protocol.  
4.3.4.2      Binding Reaction 
The oligonucleotides encompassing the putative Irx5 binding site in the Kv4.2 promoter 
(-1013~ -958) were generated by PCR using primers with or without a biotin group at the 5’-end 
(Table 8).  The amplified fragment was then purified using QIAquick gel extraction kit 
(QIAGEN, Valencia, CA) according to the manufacturer’s instruction.  The biotin-labeled 
fragment was used as a probe, while the unlabeled products were served for competition with the 
probe in the binding.   
The binding reactions were performed with the biotin-labeled probe using LightShift 
chemiluminescent EMSA kit (Pierce Chemical Co., Rockford, IL) according to the 
manufacturer’s instruction.  Briefly, nuclear proteins were first added to the reaction mixture 
containing 1x binding buffer, 50 ng/μl Poly (dI·dC) and incubated for 5 minutes at room 
temperature.  Then the biotin-labeled oligonucleotide (20 fmol) was added in a final volume of 
20 μl and the incubation was further continued for 20 minutes.  In competition assays, 200-fold 
molar excess of unlabeled oligonucleotides were added at the start of the reaction.   
 83 
Table 8.   Oligonucleotides Used in EMSA 
DNA Fragment Forward Reverse 
-1013~ -958 5’-
TCTCCCTTGGTGACA
TTTGG-3’ 
5’-
TCTCGCTCCACCCTA
GCCAC-3’ 
-1002~ -966 5'phospho-
CATTTGGCGTC 
GAGGCTGGTGGGTG
GCTAGGGTGGA-3’ 
5’phospho-
TCCACCCTAGCCAC  
CCACCAGCCTCGAC
GCCAAATG-3’ 
                  
4.3.4.3     Electrophoresis  
The bound complexes were separated on a 6% polyacrylamide gel at 4 ºC in 0.5% TBE 
and transferred to Hybound-N+ membrane (GE Healthercare, Piscataway, NJ).  The biotin-
labeled DNA was detected using the LightShift chemiluminescent EMSA kit according to the 
manufacturer’s instruction.  Chemiluminescence images were captured and analyzed using 
charged-coupled device camera-based system.  
4.3.5      Statistical Analysis 
Each data value was obtained from duplicate assay.  Data values from at least three 
independent experiments were used for statistical analysis.  Statistical comparison was 
performed by one-way ANOVA followed by Bonferroni’s posthoc test with a significance level 
of 0.05 or greater using Prism 5.0 (GraphPad Software, San Diego, CA).  Results are expressed 
as mean ± SEM.   
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4.4 RESULTS 
4.4.1      Multiple Regions Are Required for the Full Activation of Kv4.2 Promoter by 
Irx5 
This laboratory previously isolated and characterized the promoter for the rat Kv4.2 gene 
(36).  Transcription of this gene initiates at 552 bp upstream from the translation site in the brain 
and heart.  In addition, the region between -3162 to -1094 exhibits inhibitory effects in cardiac 
myocytes and neuron-like PC12 cells.  Hence, to identify the sequence that might be responsible 
for the Irx5 effects, a series of deletion from the 5’end of the 5’flanking region (-1094~ +488) of 
rat Kv4.2 promoter were generated.  The generated fragments were tested for the promoter 
activity in the presence and absence of Irx5 in 10T1/2 cells (Fig 15A).  The basal activity in the 
absence of the transcription factor was similar in all deletion constructs.  The degree of Irx5-
induced activation significantly differed between deletion constructs (Fig 15B).  The longest 
promoter construct (-1073 ~+519) drove a ~8 fold increase (Fig 15B).  Deletion of the region 
from -1002 to -966 halved the induction by Irx5 (fold change by Irx5 in a deletion construct 
compared to that of the longest promoter construct, p<0.05, n>5 for each construct, Bonferroni’s 
test).  These findings indicate that multiple portions in the Kv4.2 5’flanking region mediate Irx5-
induced activation of the channel promoter.  They also suggest that the 36-bp portion (-1002~ -
966) contains an element that is required for the full activation of channel promoter by Irx5.   
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 Figure 15.   Multiple regions are required for the full activation of Kv4.2 promoter by Irx5. 
A. Various portions of the Kv4.2 5’flanking region (filled bars) were fused to the upstream of the luciferase gene 
(open bars) of pGL3-basic vector.  Numbers represent the positions in bp with respect to the transcription initiation 
site.  B. 10T1/2 cells were co-transfected with one of these 5’-deletion constructs containing different promoter 
regions, expression vector for rIrx5 or empty vector and pRL-tk.  Luciferase activity was normalized with the 
activity of co-transfected pRL-tk, and is presented as fold increases by Irx5 (Irx5 expression vector/empty vector).  
Columns and error bars represent the means and S.E.M., respectively.  N≥5 for each construct.  *p<0.05 and *** 
p<0.005 compared to the longest promoter construct (-1073~ +519). 
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4.4.2      The ~1-kb Kv4.2 5’-flanking Region Enhances a Heterologous Promoter in 
Reponses to Irx5 
A classical enhancer acts independently of the promoter, direction or location.  To test if 
the distal promoter region of Kv4.2 may possess these characteristics, the ~1-kb region (-1073~ -
98) was cloned into the vector containing a heterologous SV40 core promoter.  When the ~1-kb 
region (-1073~ -98) was placed in front of the SV40 minimum promoter, Irx5 significantly 
increased promoter activity by ~four-fold (Fig 16A).  The ~1-kb fragment in the reverse 
orientation did not produce any change in promoter activity in response to Irx5.  Thus, this 
region contains a direction-dependent Irx5-responsive element.  To narrow down the region 
responsible for the Irx5-induced activation of the heterologous promoter, the ~1-kb region was 
divided into three portions (Fig 16B).  The 5’ and 3’ part of the region supported significant 
(~two-fold) increases in promoter activity by Irx5, but none of them restores the activity 
mediated by the full length (~1-kb) of the region, suggesting a synergetic effect of the two parts.  
The middle region also tended to increase promoter activity upon Irx5 expression.  These data 
further support the presence of multiple Irx5-responsive elements in the distal 5’flanking region 
of Kv4.2 promoter.   
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Figure 16.  The distal 5'-flanking region of Kv4.2 promoter activates the SV40 minimum promoter in 
a direction-dependent manner. 
A.  The ~1-kb fragment of the 5’-flanking region of Kv4.2 promoter (-1073~ -98) was fused to pGL3-promoter 
vector which contains the SV40 promoter upstream of the luciferase gene.  R denotes the ~1-kb fragment (-1073~ -
98) in the reverse direction.  Fold changes by Irx5 determined as described in the legend for Fig. 14B.  Columns and 
error bars represent the mean and SEM.  *p<0.05 compared to pGL3-promoter vector (n=4 for each construct).  B. 
The ~1-kb fragment of the 5’-flanking region of Kv4.2 promoter (-1073~ -98) was divided into three parts with each 
~500 bp in length: -1073~ -572, -596~ -98, and -876~ -329.  These different regions were fused to the heterologous 
promoter (SV40).  Columns and error bars represent the mean and SEM.  *p<0.05 compared to pGL3-promoter 
vector (n=3 for each construct).  
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4.4.3       A GT-rich Element in the 36-bp Region is Required for the Irx5-induced 
Enhancement of Promoter Activity. 
 Deletion analysis indicated that the 36-bp region (-1002~ -966) is required for the 
maximum activation of Kv4.2 promoter by Irx5.  Thus, the identified 36-bp region (-1002~ -966) 
might be sufficient to stimulate a heterologous promoter in response to Irx5.  One, two or four 
copies of the 36-bp region were placed in front of the SV40 core promoter in a luciferase vector.  
Reporter gene assays showed that this 36-bp fragment mediates stimulation of the heterologous 
promoter by Irx5 (Fig. 17).  The increase tended to be larger when more copies were introduced.  
These results indicate that the identified 36-bp region (-1002~ -966) contains an Irx5-responsive 
element.  They also suggest that this region mediates, in part, the upregulation of Kv4.2 promoter 
by Irx5.  
 The sequence of this 36-bp region contains several potential elements that can mediate 
the Irx5 response.  Notably, a non-canonical E-box (CANNTG) is located at the 5’end, whereas a 
GT-rich sequence (GGTGGGTGG) is seen in the middle (Fig. 18A).  Previous studies have 
shown the importance of E-box and GT-rich elements in the regulation of various cardiac and 
other genes (91-95).  To determine if these elements are required for the Irx5-induced activity in 
10T1/2 cells, four copies of the 36-bp fragment that contains mutations in either the E-box or 
GT-rich motif were inserted into pGL3-promoter vector (Fig 18B).  Transient transfection assays 
indicated that Irx5 caused 2~3-fold enhancement of the promoter activity with wild-type element 
(-1002~ -966) x4 (Fig. 18B) (p<0.01).  Mutations of the E-box motif did not affect the Irx5 
response (p<0.01).  In contrast, destroying the GT-rich sequence eliminated the activation of the 
promoter activity by Irx5.  These results indicate that the GT-rich element in the identified 36-bp 
region acts as an Irx5-responsive element.   
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 Figure 17.   The 36-bp fragment (-1002~ -966) shows enhancement of a heterologous promoter 
(SV40) in response to Irx5. 
One, two, or four copies of the 36-bp fragment (-1002~ -966) in the Kv4.2 distal promoter region were placed in 
tandem in the pGL3-promoter vector: construct (-1002~ -966) x1, (-1002~ -966) x2 and (-1002~ -966) x4.  Fold 
changes by Irx5 are shown with columns and error bars indicating the mean and SEM.  *p<0.05, **p<0.01 and *** 
p<0.005 compared to pGL3-promoter vector (n=5 for each construct). 
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 Figure 18.   A GT-rich element (GGTGGGTGG) in the 36-bp fragment is responsible for the activity 
by Irx5. 
A.  The 36-bp region contains the consensus sequence for E-box and GT-rich elements (highlighted with boxes), 
which are known to control transcription of various cardiac and other genes (top).  Point mutations were introduced 
to eliminate the consensus for these elements (middle for E-box and bottom for GT-rich region).  B. Four copies of 
the original and mutated 36-bp elements were inserted in pGL3-promoter vector containing the SV40 promoter 
upstream of the luciferase gene.  Each wild-type or mutated construct was cotransfeted with pRL-tk with Irx5 
expression construct or empty vector into 10T1/2 cells.  Normalized luciferase activity (GL/RL) was used for 
comparison.  Columns indicate the ratio of Irx5 expression vector/empty vector with error bars representing SEM. 
**p<0.01 compared to pGL3-promoter vector (n≥3 for each construct). 
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4.4.4     The 36-bp Region of Kv4.2 Promoter (-1002~ -966) Binds to an Endogenous 
Nuclear Protein.  
Irx5 might activate promoter activity by directly binding to the 36-bp region (-1002~ -
966).  To test this hypothesis, nuclear extracts were prepared from rIrx5-pcDNA3- or empty 
vector-transfected Ad293 cells.  The obtained nuclear proteins were tested for the binding to this 
identified region using electrophoretic mobility shift assay (EMSA) with a biotin-labeled 55-bp 
fragment (-1013~ -958) encompassing the 36-bp region (-1002~ -966).  A specific band was 
observed in EMSA assays in both control and ectopic Irx5-expressing extracts (Fig 19).  This 
band was eliminated when excess competitor was included in the binding reaction.  No apparent 
differences in the size or intensity of this band were detected between control and Irx5-
containing extracts.  A similar binding of endogenous proteins was also seen with nuclear 
extracts from 10T1/2 cells, although the intensity of the band was much weaker (data not shown).  
These results indicate that Irx5 does not bind to the 36-bp region directly.  The observed 
enhancement of promoter activity by Irx5 may involve a more complex indirect action of the 
transcription factor. 
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 Figure 19.   The 36-bp region (-1002~ -966) of Kv4.2 promoter binds the endogenous proteins in 
10T1/2 cells. 
EMSA experiments were performed with nuclear extracts from rIrx5-pcDNA3 or empty vector transfected ad293 
cells using biotin-labeled probes containing the identified 36-bp region (-1002~ -966).  Unlabeled DNA (200-fold 
excess) was used to eliminate specific binding to the probe.  An arrow indicates the position of binding complex 
which was eliminated with excess unlabeled probes.  Note that no apparent difference in the size or intensity 
between Irx5 and Mock. 
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4.5 DISCUSSION 
During the last 20 years, many studies have shown the importance of Iroquois (Irx) 
atypical homeodomain-containing proteins for various developmental processes.  Using loss- and 
gain-of-function approaches, these studies have resulted in a wealth of information about their 
roles in neural, cardiac and lung development (26, 27, 42, 96, 97).  Yet, far less is known about 
their target genes and regulatory DNA-binding sequences.  In a recent study by Costantini et al., 
Kv4.2 has been identified for the first time as a target gene of Irx5 using Irx5-defient mice (2).  
However, no cis-element that regulates the transcription of Kv4.2 gene has been defined in any 
system.  This study carried out a thorough analysis of the ~1-kb 5’flanking region of rat Kv4.2 
gene.  Deletion analysis indicated that multiple portions are required for the full activation by 
Irx5.  In particular, the 36-bp fragment (-1002~ -966) appeared to respond to Irx5 to increase the 
activity of its own and heterologous promoter (SV40).  This Irx5-induced enhancement with the 
36-bp, as well as the entire 5’flanking region, depended on the orientation of the fragment.  
EMSA assay failed to detect a specific binding of this region with Irx5.  These observations 
suggest that Irx5 exerts its transcriptional regulation by influencing other as yet unidentified 
factors via diverse cis-regulatory elements.  
The data in this chapter identified a 36-bp region (-1002~ -966) that is critical for Irx5-
dependent regulation of Kv4.2 gene transcription in 10T1/2 cells.  This fragment was also able to 
confer the Irx5-responsiveness to a heterologous promoter.  Mutation analysis showed a GT-rich 
element (GGTGGGTGG) is responsible for the activity of this region.  This GT-rich element 
was originally reported as a retinoblastoma control element (RCE) (93).  This element appears to 
be essential for the retinoblastoma (RB) protein-mediated transcription of many genes, including 
c-Fos, c-Myc and TGF beta 1.  It has been shown that Sp1 proteins are also capable of binding to 
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this motif (98) and interacts with RB to regulate gene transcription.  This Sp1-like element is 
thus proposed to cooperate in the Sp1-mediated transcription system, which is further modulated 
by other transcription factors, including Rb and p53, to regulate the expression of some 
housekeeping genes (94, 99).  More importantly, this GT-rich element has also been implicated 
in the regulation of gene transcription by other Iroquois proteins.  The expression of Hb9, an 
embryonic motor neuron gene, is repressed by Irx3 and Nkx2.2 in chicken embryo (82).  It is 
proposed that Irx3 together with Nkx2.2 inhibits the transcriptional activation of Sp1 on the Hb9 
promoter.  In addition, the 36-bp fragment containing this element was found to bind to some 
endogenous proteins in this study, although the specific DNA binding sequence within this 
fragment is presently unclear.  Taken together, these observations suggest that Irx5 influences 
Kv4.2 channel promoter by, at least in part, altering the activity of transcription factor complexes 
that bind to this element.   
10T1/2 cells were used for analysis of Kv4.2 promoter in this chapter.  This raises the issue 
of whether Irx5 regulates channel promoter via the same DNA elements in cardiac myocytes.  
The deletion analysis in this and previous studies from other laboratory (2) made similar 
observations that Irx5 has opposite regulatory effects on the Kv4.2 gene promoter activity in 
myocytes and non-myocytes.  In particular, the most dramatic decline in the Irx5-induced 
regulation is seen when the region between -1073 and -414 is eliminated in both cell types.  
Moreover, the previous chapter established the pivotal role of Irx5 in controlling channel gene 
transcription in both cell types.  These observations justify analysis in this study focusing on this 
region.  However, it is certainly possible that distinct elements located within this region 
differentially mediate the activation in 10T1/2 cells and the inhibition in cardiac myocytes.  
Thus, further studies focused on the roles of the identified 36-bp region and GT-rich element in 
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regulating Kv4.2 gene expression in cardiac myocytes are needed to provide insights into 
detailed molecular mechanisms underlying the regulation of Kv4.2 gene transcription in cardiac 
myocytes.    
Although the identification of the partners of Iroquois proteins await further investigation, 
it is reasonable to conclude that this 36-bp fragment (-1002~ -966) is essential for the 
transcriptional regulation of Kv4.2 gene by Irx5 in fibroblast cells.  The observations made in 
this chapter favor a model in which multiple regions are involved in the regulation of Kv4.2 gene 
transcription.  Interestingly, a recent study revealed that Irx7 activates transcription of a neuron-
specific gene, Krox20, via a cis-regulatory element in GFP reporter assay (100).  While Irx7 
failed to bind to this cis element, the in vivo ChIP assays showed that Irx7 binds to the core 
promoter region, suggesting the existence of a chromatin loop formed between distal and 
proximal promoter.  Therefore, the Irx5 regulation of Kv4.2 promoter may also involve a similar 
mechanism of the interaction between the distal and proximal promoters at the chromatin level.  
In addition, this process may also require complex interactions of Irx5 with other factors.  Thus, 
it is of great interest to determine the roles of not only distal but also proximal elements, as well 
as their interactions in future studies.  
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5.0  SUMMARY AND CONCLUDING REMARKS 
5.1 SUMMARY 
It has been several decades since the importance of electrical heterogeneity for the proper 
cardiac function has been recognized.  Yet, only the last 10 years have seen molecular 
understanding of this physiologically-important phenomenon.  The cloning of a wide variety of 
voltage-gated ion channels revealed that various shapes and durations of cardiac action potential 
are generated by the assortment of ion channels present in each cell.  While the upward 
movement of membrane potential is primarily due to molecularly-identical voltage-gated sodium 
channel in atrial and ventricular myocytes, the downward repolarization is set by diverse 
potassium (K+) channels.  Specifically, the voltage-gated transient outward K+ (Ito) channels 
consisting of Kv4.2 and/or Kv4.3 pore-forming and auxiliary KChIP2 subunits are the major 
determinant of cardiac action potential.  The expression level of Kv4.2 largely determines the 
shape and duration of action potential in rodent hearts.  Thus, the present study is aimed at 
elucidating transcriptional regulation of the rat Kv4.2 gene.  
This study has demonstrated that the atypical homeodomain Iroquois (Irx) family 
proteins, Irx4 and Irx5, cooperatively regulate the transcription of Kv4.2 gene.  Irx5 acts as a 
primary regulator of Kv4.2 gene transcription, while Irx4 is a suppressor of the Irx5 action.  In 
non-myocytes where no endogenous Irx4 or Irx5 is present, Irx5 activates Kv4.2 gene promoter 
 97 
(Fig. 20).  Irx4 prevents this stimulation of channel promoter by Irx5.  A reduction in Irx4 with 
siRNA restores the stimulatory effect of Irx5 in neonatal ventricular myocytes.  These results 
indicate that Irx5 acts as a transcription activator in both cardiac myocytes and non-myocytes.  
They also suggest that abundantly-expressed Irx4 continuously prevents the activation of Kv4.2 
gene transcription by Irx5 in cardiac myocytes.  However, this interplay between Irx4 and Irx5 
cannot account for the inhibition of Kv4.2 promoter by Irx5 in cardiac myocytes.  Instead, this 
inhibition by Irx5 could only be explained by assuming the presence of an additional myocyte-
specific molecule that interacts with Irx5 to decrease the activity of channel promoter (Fig. 20). 
 
Figure 20.  Proposed model for the regulation of Kv4.2 gene transcription by Iroquois family 
proteins. 
The present study also provides new insights into the molecular actions of TALE atypical 
homeodomain proteins.  TALE atypical homeodomain proteins may produce their transcriptional 
regulation by directly binding to a specific DNA sequence; alternatively, these proteins indirectly 
control gene transcription by affecting other transcription factors.  The present study supports the 
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latter possibility for the activator action of Irx5.  Deletion and mutation analyses of the Kv4.2 
5’flanking region revealed that multiple regions are required for the full activation by Irx5.  One 
small region, a 36-bp portion, appears to stimulate own and heterologous promoters in response 
to Irx5.  This enhancement requires a GT-rich element (GGTGGGTGG), a potential binding site 
for SP1 and other factors.  Furthermore, the C-terminal peptide of Irx5 is necessary and 
sufficient for its activation of channel promoter.  These findings indicate that Irx5 activates 
Kv4.2 gene promoter indirectly by interacting with endogenous transcription factors via its C-
terminal peptide.  The results in this study also indicate that the regulatory action of Irx4 
involves other proteins.  The N-terminal peptide of Irx4 appears to mediate this effect.  Moreover, 
addition of histone deacetylase inhibitor (TSA) relieves the inhibitory effect of Irx4.  Therefore, 
it is possible that Irx4 produces its suppression of the Irx5 action by modifying the structure of 
chromatin and recruitment of histone deacetylase.   
Taken together, the present study has shown that the interplay between the two atypical 
homeodomain proteins, Irx4 and Irx5, controls the transcription of rat Kv4.2 gene.  These actions 
of Irx proteins involve some housekeeping and/or cell-type specific transcription factors.  Hence, 
the levels of these factors, as well as the ratio of the two Irx proteins, determine the outcome of 
channel transcription and electrical phenotype in each cell. 
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5.2 HETEROGENEOUS EXPRESSION OF KV CHANNEL GENES AND IROQUOIS 
FAMILY MEMBERS IN THE HEART 
Studies conducted over the past twenty years or so have demonstrated that mammalian 
ventricular myocardium is not homogeneous with respect to repolarization characteristics.  
Ventricular epicardium and midmyocardium display action potentials with a prominent transient 
outward potassium current (Ito)-mediated early phase, giving rise to a notched appearance of the 
action potential.  The absence of this prominent notch in the endocardium is a consequence of a 
much smaller Ito.  Similar regional differences in Ito are found in canine, feline, rabbit, rat and 
human ventricular myocytes.  Consistent with these previous findings, the data in chapter 1 
showed that there is a transmural gradient of Kv4.2 gene expression in rat heart with higher 
expression in epicardium.  Also there is a uniform expression of Kv4.3 gene across the left 
ventricle wall of rat heart.  
Several studies have shown that mRNA stability plays an important role in controlling 
Kv4.3 expression in cardiac myocytes (45, 101, 102).  However, previous studies have found no 
change in Kv4.2 mRNA stability upon treatment with various hormones or chemicals in neonatal 
myocytes, or consensus sequences for known elements in the 3’ untranslated region of Kv4.2 
mRNA that potentially influence mRNA stability [(45), unpublished observation in our 
laboratory].  Therefore, it is likely that this regional variation in channel gene expression reflects 
a pattern of differential transcriptional regulation within the ventricle.  On the other hand, a 
recent microarray analysis identified differential expression of the two Iroquois transcription 
factors, Irx3 and Irx5, across the left ventricular wall (1).  Since Irx proteins control various 
developmental patterning, they may control the region-selective transcription of downstream 
functional genes in the heart.  The full examination of the expression patterns of all Irx family 
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members and some related factors in this study demonstrated that Irx3 and Irx5 are expressed in 
a steep gradient across the left ventricular wall in an inverse pattern to the expression of Kv4.2 
gene.  Irx4 is equally abundant throughout the ventricular tissue and absent from atrium.  Other 
Irx members were either undetectable or very low without any region selectivity (data not 
shown).  These findings strongly suggested that differentially-expressed Irx3 and Irx5, as well as 
abundant Irx4, act as upstream regulators to control the region-selective transcription of 
downstream functional genes including Kv4.2 in rodent hearts.  Although less is known about 
regional differences in expression of functional genes except Ito-forming channel subunits, it is 
possible that Irx3 and Irx5 are involved in transcriptional control of other functional genes that 
play pivotal roles in cardiac functioning.  It is also important to note that differential expression 
of Irx3 and Irx5 is also seen in the heart of large animals, such as dogs (1).  In the left ventricular 
wall of large animals, the auxiliary subunit KChIP2, but not the pore-forming Kv4.2, is 
differentially expressed (7).  Therefore, Irx3 and/or Irx5 may also control differential 
transcription of KChIP2 gene in the ventricle of large animals.   
While the identified roles of Irx proteins are consistent with the expression pattern of 
Kv4.2 gene across the left ventricular wall, the relationship in expression levels between Irx 
proteins and Kv4.2 gene does not hold true for some other parts of the heart.  For example, the 
expression of Irx5 mRNA was very low in atria and Irx4 is nearly undetectable in these tissues.  
If the ratio of Irx4/Irx5 is the sole indicator of Kv4.2 gene transcription, then Kv4.2 gene 
expression should be very low in atria.  Surprisingly, the level of Kv4.2 mRNA was comparable 
to that in the right ventricle.  A simple explanation for this discrepancy is the presence of factors 
that confer the inhibitory action of Irx5 in ventricles, but not in atria.  If this is the case, then Irx5 
could act as an activator of Kv4.2 gene transcription in atrial myocytes, similar to the action of 
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Irx5 in 10T1/2 cells in this study.  Thus, a putative factor that confers the inhibitory action of 
Irx5 may be specifically expressed in ventricular myocytes, but not in atrial myocytes. 
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5.3 ROLE OF IRX5 ON KV4.2 GENE EXPRESSION 
Despite the significant roles of Iroquois (Irx) proteins in regulating pattern formation 
during development and adulthood, very little is known about the mechanism by which these 
proteins exhibit their transcriptional and functional specificities.  This is in part due to very few 
direct targets of Irx proteins that have been identified.  Irx5-induced regulation of Kv4.2 gene 
provides a prime candidate to address this issue.  The promoter analysis of Kv4.2 gene in 
fibroblast cells in the chapter 3 suggests the indispensability of a 36-bp region (-1002~ -966) of 
Kv4.2 gene promoter in mediating the action of Irx5, although this region alone cannot fully 
reproduce the stimulation by Irx5 observed with the longer region (-1073~ -98).  Indeed, there 
were significant effects with other parts of the promoter region in response to Irx5 in 
heterologous promoter assays.  These results suggest a synergetic effect of the different promoter 
regions.  The data presented here favors a model where the transcriptional activity of Irx5 on 
Kv4.2 gene in non-myocytes requires the involvement of unidentified proteins at multi-loci over 
the distance, while the chromatin might form a loop between the distal and proximal promoters 
to facilitate the interaction of these transcription factors including Irx5.  
During the course of this study, the role of Irx5 on the regulation of Kv4.2 gene (Kcnd2) 
expression within ventricular myocytes has also been reported by a couple of groups.  The one 
group has generated Irx5-deficient mice.  These mice showed increased expression of Kv4.2 
gene in endocardium, resulting in ventricular repolarization abnormalities with predisposition to 
develop arrhythmias (2).  The other work has located Irx5 expression in the downstream of 
microRNA.  Upregulation of Irx5 in microRNA-deficient mouse correlates well with decreased 
transcription of Kv4.2 gene in the heart (103).  Consistent with these observations, Irx5 appears 
to decrease the channel promoter activity in neonatal ventricular myocytes in this study.  This 
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supports the general role of Irx proteins as transcriptional repressors, as has been observed with 
other Irx members.  For example, Irx3 has been shown to repress the transcription of the Hb9 
gene in chicken embryo (82).  Likewise, Xiro 1, a member of Irx proteins in Drosophila, is 
reported to function as a transcriptional repressor to down-regulate the expression of Wnt by 
direct binding to the promoter to allow neural plate formation (40).  Since Irx5 produces the 
opposite outcomes in myocytes and non-myocytes, it is likely that Irx5 inhibits the 
transcriptional activation of unidentified myocyte-specific factors, but not directly binds to the 
channel promoter region.  Hence, further studies on the identification of this putative myocyte-
specific activator may be necessary for understanding the role of Irx5 in the region-selective 
expression of Kv4.2 gene in the heart.   
In contrast to the inhibitory action in myocytes, Irx5 activates Kv4.2 gene promoter in 
non-myocytes.  This activator action of Irx5 was seen in various non-myocytes, such as 10T1/2, 
Ad293 (HEK293) and PC12 cells.  In addition, reducing Irx4 expression unmasked the activator 
action of Irx5 in neonatal ventricular myocytes.  Moreover, this study revealed that Irx5 is 
moderately expressed in atria, whereas Irx4 is nearly undetectable in these tissues.  Therefore, 
significant expression of Kv4.2 in these tissues is likely due to the activator action of Irx5.  
These findings support a universal role of Irx5 as a transcription activator of Kv4.2 gene in any 
cell types in the absence of Irx4.  These observations also reflect different levels of coregulators 
for Irx actions present in ventricular myocytes and non-myocytes.  First, the lack of the certain 
myocytes-specific activators may give rise to the low basal level of Kv4.2 gene in non-myocytes.  
Second, the C-terminal region of Irx5 is required for promoter activity suggests an indirect effect 
of Irx5 by association with some as yet unidentified ventricular myocyte-specific proteins in 
regulating the channel promoter activity.  For instance, Irx5 may direct Kv4.2 gene transcription 
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via its C-terminal peptide to either activate or inhibit channel promoter by contact with local 
factors depending on the context.  
The current study provides several potential candidates for the unidentified co-factors of 
Irx5 in transcriptional activation of Kv4.2 gene in non-myocytes.  The data in the chapter 3 
demonstrated an important GT-rich element (GGTGGGTGG) in mediating the promoter 
activation by Irx5.  This DNA sequence has been documented as the binding site of Sp1, Sp2, 
and Sp3 which share extensive homology at the zinc-finger domain (92).  Similarly, Irx3, 
another Irx family member, has been proposed to repress the transcription of the Hb9 gene in 
chick embryo by preventing the transcriptional activity of Sp1 on the promoter (82).  This 
process requires the involvement of Nkx2.2, a classic homeodomain protein.  Identification of 
the proteins that binds to this region will clarify the regulatory roles of these putative and Irx 
proteins in the regulation of Kv4.2 gene.   
 
 
 
 
 
 
 
 
 
 105 
5.4 ROLE OF IRX4 ON KV4.2 GENE EXPRESSION 
Irx4 has been shown to inhibit the transcription of the cardiac slow MyHC3 gene 
expression in myocytes and to down-regulate the expression of Slit 1 within the retina.  
However, Irx4 does not exclusively function as a repressor in the regulation of gene 
transcription.  For example, a loss-of-function study in Zebrafish has suggested that Irx4 
positively regulates the expression of Sox2 during development of the hindbrain placodes (104).  
Likewise, the disruption of Irx4 in mice increased expression of ventricular eHand among other 
genes whose expression were de-repressed (26).  However, most of these studies employed gain-
of-function or loss-of-function approaches in the entire animals.  Given the complex situation in 
vivo, it is difficult to predict the direct actions of Irx4.  Also, the dominant-negative form of Irx4 
created by fusion of the Irx4 homeodomain with the repressor domain of Engrailed used in many 
studies is predicted to interfere with the actions of multiple Irx family members.  Thus, the 
precise role of Irx4 in regulating gene transcription remains obscure.  This study used a well-
defined culture system to demonstrate that Irx4 possesses the ability to regulate Kv4.2 promoter.  
It further established a repressor action of this transcription factor in channel gene transcription. 
It is important to note that Irx4 alone does not affect Kv4.2 channel promoter activity in 
either myocytes or non-myocytes.  Rather, it exclusively prevents the promoter activity induced 
by Irx5.  This effect is mediated by the N-terminal peptide of Irx4.  This is very similar to a 
previous report that Irx4 lacks direct action on the slow MyHC3 promoter, but represses the gene 
transcription by association with co-factors via its N-terminal region (29).  Therefore, it may be a 
general scheme that Irx4, like other Irx members, controls gene transcription indirectly by 
interacting with other transcription factors, instead of directly binding to a DNA element.   
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5.5      THE INTERPLAY OF IRX4 AND IRX5 IN REGULATING KV4.2 GENE 
EXPRESSION 
Iroquois proteins are known to be redundant and functionally interchangeable in flies.  A 
deletion of at least two of the three Drosophila Iroquois genes araucan, caupolican, and mirror 
is required to cause a morphological defect, while deletion of all three results in more-profound 
abnormalities (52, 105, 106).  However, there is always suspicion that this is not the case in 
vertebrates.  For example, in the mouse developing heart, Irx genes exhibit distinct expression 
patterns (26, 27, 44, 107).  Moreover, the data in the chapter 1 demonstrated the functional 
specificity of Irx members in regulating Kv4.2 promoter.  Irx5, not Irx3 or Irx4, directly controls 
the activity of channel promoter via its unique C-terminal peptide, whereas Irx4, but not Irx3, 
prevents the Irx5-induced regulation of channel promoter by its N-terminal region.  These 
findings establish the unique functional roles of individual Irx members.  Hence, Irx proteins are 
not only expressed in distinct patterns, but also possess the unique structural features that are 
necessary for their individual roles.   
 This study established that Irx4 represses transcriptional activation of Kv4.2 promoter by 
Irx5.  This action of Irx4 can be achieved by several possible ways.  At molecular interaction 
level, all Irx proteins contain a highly conserved atypical homeodomain.  Therefore, it is 
conceivable that Irx4 might prevent the Irx5 action by competing for a DNA element with Irx5.  
However, Irx3 appears to lack the ability to inhibit the Irx5-induced activation of channel 
promoter.  Thus, a simple competition of a cis element is less likely.  Similarly, Irx4 might 
interfere with the binding of Irx5 to a putative regulatory protein.  Again, the lack of inhibition 
by Irx3 is against this possibility.  Another possible molecular interaction on which Irx4 may 
influence is homomeric association of Irx5.  In this case, the lack of inhibitory action by Irx3 can 
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arise from the neutrality of this factor, in which Irx5-Irx3 heteromers are still capable of inducing 
transcriptional activation.  The data in the chapter 2 suggest non-selective association between 
Irx family members, although complex formation is very inefficient in vivo.  This is consistent 
with a previous biochemistry study that Drosophila Irx proteins can form homo- or hetero-
dimers (50).  Therefore, Irx4 might form heteromeric complexes with Irx5 to reduce the 
formation of Irx5 homomeric dimers that is required for the activation of channel promoter.  
However, no heteromeric complexes between Irx4 and Irx5 were detected using a mammalian 
two-hybrid system.  Although this discrepancy might be due to methodological reasons, such as 
inefficient nuclear localization of the heteromeric complexes, the results suggest less effective 
association between Irx proteins.  Furthermore, N-terminal and most C-terminal regions of Irx 
proteins outside the highly-conserved atypical homeodomain are highly diverse.  Thus, potential 
self-association may be mediated by very limited homologous regions within Irx polypeptides.  
Therefore, complex formation between Irx proteins is considered to be less stable or weak, if 
any, under physiological conditions.  Finally, Irx4 might produce its inhibitory action 
independently of the molecular interaction of Irx5.  For example, Irx4 may act at a downstream 
of the Irx5-induced signaling pathway leading to the activation of Kv4.2 promoter.  However, 
the similarity between Irx member proteins and the observed dose dependency argue against this 
possibility.  Further studies on the structure and roles of individual domains of Irx proteins may 
be needed to identify the precise molecular interactions involved in the inhibitory action of Irx4. 
It is also important to identify cellular mechanisms by which Irx4 produces its inhibitory 
action on the Irx5-induced activation of Kv4.2 promoter.  One possible mechanism is enhanced 
exportation of Irx5 transcriptional complexes from the nucleus.  This is consistent with the 
observations that Irx4-fusion proteins in a mammalian two-hybrid system generated low 
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luciferase signals.  There is evidence that TALE atypical homeodomain proteins regulate gene 
transcription by affecting the nuclear localization of other transcription factors (77).  Another 
possibility is that the participation of Irx4 prevents transcriptional initiation from the channel 
promoter.  The N-terminal peptide of Irx4 appears to be sufficient to produce the inhibition of 
the Irx5-induced activation of Kv4.2 promoter activity.  A previous mechanistic study on the 
transcriptional regulation of the slow MyHC3 gene also suggested the requirement of the N-
terminal region of Irx4 in interacting with other co-factors in regulating gene transcription (29).  
Therefore, this peptide region is considered to interact with other proteins to exert its inhibitory 
action on the Irx5-induced regulation.  Taken together, Irx4 may form unstable complexes with 
Irx5 to incorporate other proteins via its N-terminal peptide.  These incorporated proteins may in 
turn prevent Irx5 to exhibit the activator action.  The drug experiments in this study also 
suggested that Irx4 might incorporate histone deacetylase into complexes.  The same observation 
was made by Costantini DL et al. in dissecting the regulatory mechanism of Irx5 on Kv4.2 
expression, although they proposed a different co-repressor (2).  The importance of histone 
acetylation has been gaining much attention and found in many instances in various regulatory 
processes.  In general, acetylated histones marked active chromosomes.  Thus, incorporation of 
histone deacetylase reduces gene transcription.  It remains unknown whether the Irx4 N-terminal 
peptide directly binds to any histone deacetylase or indirectly incorporates these enzymes into 
complexes.  
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5.6 FUTURE DIRECTION 
The regulation of Kv4.2 gene transcription by Iroquois (Irx) proteins represents not only a 
physiologically important phenomenon, but also a prime situation to elucidate molecular actions 
of atypical homeodomain transcription factors.  There are many unanswered questions with 
regard to the actions of Irx4 and Irx5.  First, in non-myocytes, a 36-bp region was found to exert 
the activation of channel promoter by Irx5.  This 36-bp fragment appears to bind to endogenous 
proteins.  Therefore, one future experiment should direct at the identification of this endogenous 
protein.  Second, in addition to the 36-bp region, other regions are also required for the full 
activation of channel promoter by Irx5.  A better overall picture may be obtained by more 
detailed sequence analysis and mutagenesis with the entire ~1-kb fragment.  Third, the results in 
this study support the possibility that the N-terminal peptide of Irx4 interacts with endogenous 
proteins present in any cell types.  Therefore, N-terminal peptide of Irx4 may be a good probe to 
identify putative interacting proteins.  These investigations will provide insight into the activator 
action of Irx5 and its inhibition by Irx4.   
In contrast to the activator action of Irx5 in non myocytes, the inhibitory action of Irx5 in 
ventricular myocytes largely remains unexplored.  Although deletion constructs containing 
various lengths of Kv4.2 gene promoter show similar responses to Irx5 in myocytes and non-
myocytes, detailed deletion and mutation analyses have not been performed in the former cell 
type.  Therefore, transient transfection assays with various constructs will be used to determine 
whether the identified 36-bp fragment and GT-rich element responds similarly in myocytes.  In 
addition to the identification of cis elements, it would be important to identify transcription 
factors that confer the inhibitory action of Irx5 in these cells.  Further biochemical studies may 
be used to identify the partners of Irx5 in the heart.  Possible approaches for this purpose include 
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immunoisolation of Irx5-containing protein complexes from ventricular tissues, followed by 
proteomic identification of proteins in the isolated complexes.  The identified proteins would 
then be examined for their roles in regulating Kv4.2 gene transcription using reporter gene 
assays, siRNA and possibly gene targeting or virus-mediated siRNA expression in ventricular 
myocytes and animal models.    
Transmural gradient of Ito density across the left ventricular wall is seen in various animal 
species.  However, molecular mechanisms underlying this size difference differ between rodents 
and large animals.  Since Ito channels are multimeric complexes consisting of pore-forming 
Kv4.2 and/or Kv4.3 and auxiliary KChIP2 subunits, the availability of either subunit can 
determine the level of functional channels.  Whereas the expression of Kv4.2 gene correlates 
with Ito density in rodent hearts, the auxiliary subunit KChIP2 is differentially expressed across 
the left ventricular wall and may be responsible for the production of Ito gradient in large 
animals.  This species difference may arise from a number of possibilities.  Since Irx5 is 
similarly and differentially expressed in both rodents and dogs, one possibility is the presence or 
absence of Irx5-responsive element(s) in the promoter of rodent and canine Kv4.2 and KChIP2 
genes.  However, preliminary results from this laboratory suggest that human Kv4.2 promoter 
behaves similarly to the rat counterpart in response to Irx5, as well as Irx4 in the presence of Irx5 
(data not shown).  Another possibility is species differences in transcription factors that control 
Kv4.2 and KChIP2 genes.  Further studies on Irx proteins and other transcription factors, as well 
as detailed analysis of channel subunit promoters, may reveal mechanisms underlying species 
differences in the region-selective expression of these genes. 
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